---
title: "Medicine"
author: "Susmit Islam"
documentclass: memoir
output:
 pdf_document:
  extra_dependencies: ["graphicx", "subcaption", "hyperref", "pdfpages", "palatino", "tikz", "pgfplots"]
fontsize: 12pt
geometry: margin=2cm
colorlinks: true
linkcolor: blue
urlcolor: blue
toccolor: gray
---

\renewcommand{\labelitemi}{$\blacktriangleright$}
\renewcommand{\labelitemii}{$\boldsymbol\circ$}
\renewcommand{\labelitemiii}{$\bullet$}
\renewcommand{\labelitemiv}{\tiny$\blacksquare$}

\openany
\raggedbottom
\twocoltocetc
\tableofcontents

\pagebreak


# Preface {-}
What follows are my own notes on various topics in medicine,
 mostly based off of the following sources:
 
-  _Davidson's Principles and Practice of Medicine_ 23rd ed.
- _Kumar and Clark's Clinical Medicine_ 10th ed.
-  _Oxford Handbook of Clinical Medicine_ 10th ed.
-  _Long Cases in Clinical Medicine_ 2nd ed.
-  _Short Cases in Clinical Medicine_ 6th ed.

The date below tells you the last time when I edited this
 document, so refer to that if you're worried about the temporal validity
 of the contents. The chapters are arranged somewhat at random, partly
 reflecting the order in which I studied them. These notes are,
 first and foremost, for my personal use, so pardon the inconvenience.
 Over time I will try tidying things up more.
 There's probably plenty of mistakes, all my own.
 Inform me whenever you find one.\newline
 
 **Use at your own peril.**

\hfill Susmit Islam

\hfill `r Sys.Date()`

# Respiratory medicine
## Tuberculosis
### Side effects of anti-TB drugs
- **Isoniazid:**
	- Hepatitis
	- Rash
	- B$_6$ deficiency $\rightarrow$ peripheral neuropathy (so pyridoxine
	 supplement required during therapy)
- **Rifampicin:**
	- Hepatitis
	- Rash
- **Pyrazinamide:**
	- Hepatitis
	- Hyperuricaemia (rarely turns into gout)
- **Ethambutol:**
	- Retrobulbar neuritis (reversible)
	- Arthralgia
- **Streptomycin:**
	- Ototoxicity (8th nerve palsy)
	- Rash


\pagebreak
# Cardiology
## Anatomy and physiology
### Coronary circulation
\label{ssec:coronary}

- **RCA** $\rightarrow$ RA, RV, SA node (in 60% individuals),
 AV node (90%)
	- **Posterior descending artery** $\rightarrow$ posteroinferior part of
	 interventricular septum and posterior LV
 		- Branch of RCA (in 90%) or LCX (in 10%)
- **LAD** $\rightarrow$ anteriorsuperior part of interventricular septum,
 anterior wall of LV
 	- LAD is called the _widowmaker_ artery, for almost the entirety of LV
 	 is supplied by it, and so infarctions involving this have high
 	 fatality.
- **LCX** $\rightarrow$ lateral, posterior and inferior LV 
- **See also: table \ref{table:infarct-loc}**

### Electrophysiology of the heart
#### Sinoatrial node
- Spontaneous depolarization = _pacemaker potential_ (details: Fig.
 \ref{fig:heart-ap})
	- Due to small influx of Na$^+$ ions, with 2 components
	- Background inward current $I_b$
	- "_Funny_" current $I_f$
		- "Funny" as the channels are activated in hyperpolarized cells,
		 as opposed to most other voltage-gated channels, which activate
		 upon depolarization
- Atrial tissue is activated like a "forest fire", but by the time the
 potential reaches the insulating annulus fibrosus at the AV junction,
 it peters out (which is why we need the AV node to act as a "repeater")

\pagebreak

#### Action potentials in the conductive system and the myocytes
\begin{figure}[h!]
	\centering
	\includegraphics[width=.7\textwidth]{../assets/med/sa-node-myocyte-ap.jpg}
	\vspace{4mm}
	\caption{Cardiac action potentials. CaL: L-type (long-lasting) Ca$^{2+}$
	 channel, CaT: T-type (transient) Ca$^{2+}$ channel. 
	 I$_{\text{K1}}$: inward rectifier K$^+$ current,
	 I$_{\text{Na}}$: inward Na$^+$ current, 
	 I$_{\text{To}}$: transient outward K$^+$ current,
	 I$_{\text{CaL}}$: inward Ca$^{2+}$ current,
	 I$_{\text{K}}$: delayed rectifier (outward) K$^+$ current. }
	 \label{fig:heart-ap}
\end{figure}

### Effects of the autonomic nervous system on the heart
- **$\boldsymbol\beta_1$-adrenergic stimulation $\rightarrow$
 $\uparrow$force of contraction, heart rate** (+ve inotropic and
 chronotropic)
 	- $\beta_1$ stimulation $\rightarrow\bigoplus$ adenlylyl
 	 cyclase-cAMP system $\rightarrow\bigoplus$ intracellular
 	 protein kinases $\rightarrow\;\uparrow$phosphorylation of proteins
 	 including L-type Ca$^{2+}$ channels $\rightarrow$ **enhanced Ca$^{2+}$
 	 influx** $\rightarrow\;\uparrow$ FoC
	- Return of Ca$^{2+}$ to sarcoplasmic reticulum from the myocyte is
	 mediated by phospholamban, which enhances Ca$^{2+}$ reuptake into
	 the SR in its phosphorylated state. So $\beta_1$ stimulation also
	 promotes Ca$^{2+}$ removal from the myocyte, thereby enhancing
	 myocardial relaxation. Enhanced relaxation $\rightarrow\;
	 \uparrow\uparrow$ventricular filling, and the $\uparrow$FoC helps
	 the heart to pump that extra blood out properly.

### Cardiac peptides
- **ANP** (atrial natriuretic peptide)
	- Released by atrial myocytes upon being stretched
	- Vasodilator $\rightarrow\;\downarrow$BP
	- Diuretic ($\uparrow$Na$^+$ and H$_2$O excretion)
- **BNP** (brain/B-type natriuretic peptide)
	- Called so because first discovered in porcine brain extracts
	- Released by ventricular myocytes upon being stretched
	- Diuretic
- Neprilysin:
	- NOT a cardiac peptide (made by the kidney and other tissues)
	- Breaks down ANP, BNP $\rightarrow$ vasoconstrictor
	- Therapeutic target in resistant heart failure

### Haemodynamic effects of respiration
#### Effects
\renewcommand{\arraystretch}{1.5}
\rowcolors{2}{gray!20}{gray!40}
\begin{table}[h!]
\centering
\begin{tabular}{l l l}
\cellcolor{violet!60}\color{white} &
\cellcolor{violet!60}\color{white}Inspiration &
\cellcolor{violet!60}\color{white}Expiration \\
JVP & $\downarrow$ & $\uparrow$ \\
BP & $\downarrow$ (upto 10 mmHg) & $\uparrow$ \\
HR & $\uparrow$ & $\downarrow$ \\
2nd heart sound (S$_2$) splitting & $\uparrow$ & $\downarrow$ \\
Right sided murmurs & $\uparrow$ & $\downarrow$ \\
Left sided murmurs & $\downarrow$ & $\uparrow$ \\
\end{tabular}
\vspace{3mm}\caption{Haemodynamic effects of respiration}
\label{table:haemo-resp}
\end{table}

#### Mechanisms
- As the circulatory system is a closed system, if any compartment within
 it has more blood at any given time, the other compartments will have less
 blood.
- BP:
	- Inspiration $\rightarrow$ -ve intrathoracic pressure $\rightarrow$
	 $\uparrow$ venous return to RA $\rightarrow\;\;\uparrow$ RV output
	- Inspiration $\rightarrow\;\;\uparrow$ pulmonary vascular capacitance
	 $\rightarrow\;\;\downarrow$ venous return to LA $\rightarrow\;\;
	 \downarrow$ LV output $\rightarrow\;\;\downarrow$ BP
- S$_2$ splitting (i.e. delay between A$_2$ and P$_2$):
	- Inspiration $\rightarrow\;\;\uparrow$ RV filling $\rightarrow\;\;
	 \uparrow$ prolonged ejection from RV $\rightarrow\;\;\uparrow$
	 delayed P$_2$
	- Inspiration $\rightarrow\;\;\downarrow$ LV filling $\rightarrow\;\;
	 \downarrow$ faster ejection from LV $\rightarrow\;\;\downarrow$
	 faster A$_2$

## Investigation of CVS disease
### ECG
- Discussed in Sec. \ref{sec:ecg}

\subsection[CXR]{Chest X-ray\footnote{A very nice intro to CXR
 interpretation from \href{https://youtu.be/KO1eBNaIxBI}{Axis Medical
 School}. This \href{https://youtube.com/playlist?list=PL3n8cHP87ijCCF4J27hHEKKrvub0yVBPa}
 {playlist by Medzcool} is also really good.}}
- Cardiomegaly: if cardiothoracic ratio (CTR) > 0.5
- Findings according to the chamber enlarged:
	- Left atrial enlargement: 
		- Straight left heart border
		- Double cardiac shadow to the right of sternum
		- Widened carinal angle
	- Right atrial enlargement:
		- Projects from right heart border to right lower lung field
	- Left ventricular enlargement: may be due to dilation or hypertrophy
		- Cardiomegaly
		- Rounding of left heart border if hypertrophy
	- Right ventricular enlargement: dilation or hypertrophy
		- Cardiomegaly
		- Upwards displacement of apex
		- Straight left heart border


## Presenting problems in CVS disease
### Pulse
- Assess
	- Rate
	- Rhythm
	- Volume: best assessed in the carotids
	- Character: best assessed in the carotids
	- Condition of the vessel wall
	- Radio-radial and radio-femoral delays
- Volume
	- **High volume pulse**
		- AR
		- Hyperdynamic circulation
	- **Low volume pulse**
		- Shock
		- AS, MS
		- Constrictive pericarditis
		- Cardiac tamponade
		- Pulmonary htn
- Character
	- **Anacrotic:**
		- Slow rising, low volume
		- Found in **AS**
	- **Dicrotic:**
		- Double peak, one systolic, other diastolic
		- Found in enteric fever
	- **Bisferiens:**
		- Double peak, both systolic
		- Found in **combined AS and AR**
	- **Waterhammer / Collapsing:**
		- Rapid rise followed by rapid fall
		- Accentuated by raising the arm
		- Seen in **AR**
	- **Paradoxus:**
		- Cardiac tamponade
		- Chronic constrictive pericarditis
		- Acute severe asthma and COPD
		- Massive PE
	

\subsection[Heart sounds]{Heart sounds\footnote{This
 \href{https://youtu.be/dt9Ffu4T0Kw}{video by Dirty medicine}
 discusses heart sounds and murmurs together with detailed explanations.
 This \href{https://youtube.com/playlist?list=PL3n8cHP87ijDnqI8_5WQlS4tN37D6P4dH}
 {playlist by Medzcool} contains audio recordings of normal heart sounds
 and the most important abnormal heart sounds and associated murmurs.}}

#### S$_{\textbf{1}}$
- **Cause:** closure of atrioventricular valves (mitral and tricuspid)
- **Timing:** _onset of ventricular systole_
- **Best heard at: the _apex_**
- **Abnormalities:**
	- **Loud: MS (mitral stenosis)** 

#### S$_{\textbf{2}}$
- **Cause:** closure of the semilunar valves (aortic and pulmonary)
- **Timing:** _end of ventricular systole_
- **Best heard at: _left sternal edge_**
- Normally louder and higher-pitched than S$_1$
- A$_2$ louder than P$_2$ (details in this \hyperref[sssec:split]
{subsection})
- **Abnormalities:**
	- **Quiet: AR (aortic regurgitation)**
	- Loud: systemic / pulmonary htn


#### Splitting of S$_{\textbf{2}}$
\label{sssec:split}

- Normally splits as S$_2$ = A$_2$ + P$_2$, because the left ventricle
 contracts more forcefully and so the aortic valve closes earlier than the
 pulmonic valve (_"physiological splitting"_)
- During inspiration, the right heart receives more blood and the left heart
 receives less blood, and so A$_2$ happens even earlier and P$_2$ even
 later, leading to increased split.

#### S$_{\textbf{3}}$
- Cause: _rapid ventricular filling_ immediately after opening of AV
 valves
- Timing: _early diastolic_
- Best heard at:
	- **bell at apex**
	- bell because it's **low-pitched**
- Heard as "lub-dub-_dum_"
- **Normal in:**
	- Children
	- Young adults
	- Febrile patients
	- Pregnancy
- **Abnormalities:** presence of S$_3$ usually pathological after 40y age
	- **LVF**
	- **MR (mitral regurgitation)**

#### S$_{\textbf{4}}$
- Cause: _forceful atrial contraction against non-compliant / stiff
 ventricle_
- Timing: _end-diastolic_ (just before S$_1$)
- Best heard at:
	- **bell at apex**
	- bell because it's **low-pitched**
- **Always pathological**
	- **LVH** (due to htn, aortic stenosis, or HCM / hypertrophic
	 cardiomyopathy)

#### Added sounds
- **Opening snap:**
	- early diastolic, just after S$_2$
	- in mitral stenosis
	- diaphragm at apex
- **Midsystolic clicks:**
	- in mitral valve prolapse
	- diaphragm at apex
- **Pericardial / friction rub:**
	- in acute pericarditis
	- diaphragm at any part of precordium with breath held at expiration
	

\subsection[Murmur]{Murmur\footnote{Here's some awesome reviews by
 \href{https://zerotofinals.com/medicine/cardiology/murmurs/}{ZeroToFinals}
 and
 \href{https://youtu.be/teJcTTVZnzs}{DirtyMedicine} on murmurs.
 This one by \href{https://youtu.be/lFcf5a6BZGw}{Strong Medicine}
 covers the topic at a slightly deeper level with 5/6 exercises
 with actual recordings of murmurs.}}

#### Basics
- Points to assess: SCRIPT
	- Site: aortic, pulmonary, tricuspid or mitral area
	- Character: soft / blowing / decrescendo /
	 crescendo-decrescendo
	- Radiation: MR $\rightarrow$ axilla, AS $\rightarrow$ neck (carotid)
	- Intensity / grading:
		- 1: very soft (audible in ideal conditions)
		- 2: soft
		- 3: moderate
		- 4: loud, with thrill
		- 5: very loud
		- 6: heard without stetho
	- Pitch: low (caused by low velocity blood flow) / high (high velocity
	 blood flow)
	- Timing: systolic / diastolic
- Right heart murmurs $\rightarrow$ louder during inspiration
 (**RINspiration**)
- Left heart murmurs $\rightarrow$ louder during expiration
 (**LEXpiration**)

#### Features of benign murmur
- Soft
- Midsystolic
- Heard at left sternal edge
- No radiation
- No other cardiac abnormalities

#### Systolic murmurs
- **Ejection systolic murmurs**
	- Causes: **ventricular outflow obstruction**
		- AS (aortic stenosis)
		- PS (pulmonary stenosis)
	- Occur during **mid-systole** with **crescendo-decrescendo pattern**
	 (i.e. gradual rise followed by gradual fall)
- **Pansystolic murmurs**
	- Causes: **leakage of blood into low pressure chamber** from a
	 ventricle
		- MR (mitral regurgitation)
		- TR (tricuspid regurgitation)
		- VSD (ventricular septal defect)

#### Diastolic murmurs
- Low-pitched, often difficult to hear so should be examined with the bell
- **Mid-diastolic murmur**
	- Causes:
		- MS (mitral stenosis): at the mitral area and radiated to the
		 axilla
		- TS (tricuspid stenosis): at the left sternal edge
- **Early diastolic murmur**
	- Soft, blowing, decrescendo pattern (gradual fall)
	- Causes:
		- AR (aortic regurgitation)
		- PR (pulmonary regurgitation)
	- In case of "systolic regurgitations" i.e. MR/TR, due to the high flow
	 throughout systole, the murmur is pansystolic. In case of "diastolic
	 regurgitations", the blood has already mostly flown out of the aorta
	 or the pumonary trunk, leaving little blood for backflow. So in this
	 case, it's early diastolic.

#### Continuous murmurs
- Cause: **PDA (persistent ductus arteriosus)**

\begin{figure}[t!]
	\centering
	\includegraphics[width=.7\textwidth]{../assets/med/murmur.jpg}
	\vspace{7mm}
	\caption{The timing and pattern of heart murmurs}
	\label{fig:murmur}
\end{figure}

### JVP
- Reflects **rt atrial pressure**
- **Hepatojugular reflux**: pressing on the liver (rt hypochondrium)
 $\rightarrow\;\uparrow$emptying of veins into the rt atrium $\rightarrow$
 transient $\uparrow$rt atrial pressure
 	- If RVF, then the increase in JVP is more sustained

\begin{figure}[!h]
	\centering
	\includegraphics[width=.7\textwidth]{../assets/med/jvp.png}
	\vspace{5mm}
	\caption{JVP waveform}
\end{figure}

\pagebreak

## ECG
\label{sec:ecg}

### Anatomy of an ECG
\begin{figure}[h!]
	\centering
	\includegraphics[width=0.7\textwidth]{../assets/med/ecg-anatomy.jpg}
	\caption{Parts of a normal ECG}
\end{figure}

### Abnormalities of components
#### Pathological Q
- Depth > 2mm
- Height > 1mm
- Present in $\ge$ 2 leads
- Assocd with loss of R height (Q > R/4; normally Q $\le$ R/4)
- **Indicates _transmural_ myocardial necrosis**

#### Segments vs intervals
- e.g. ST segment = end of S $\rightarrow$ start of T
- PR interval = start of P $\rightarrow$ start of R

#### ST segment elevation
- Normal: upto 1mm in limb leads, upto 2mm in chest leads
- **Causes**
	- **STEMI:** **convexity** upwards
	- **Acute periCArditis:**: **conCAvity** upwards
- **Indicates ongoing myocardial injury**

### Myocardial infarction
[A somewhat interesting physiological explanation on how the changes arise](
	https://www.cvphysiology.com/CAD/CAD012
)

#### Sites of infarction based on lead
- Septal: V$_1$, V$_2$
- Anterior: V$_3$, V$_4$
- Lateral: I, aVL, V$_5$, V$_6$
- Extensive anterior: V$_1$-V$_6$
- Anterolateral: I, aVL, V$_1$-V$_6$
- Further details: table \ref{table:infarct-loc} and subsection
 \ref{ssec:coronary}

\renewcommand{\arraystretch}{1.5}
\rowcolors{2}{gray!20}{gray!40}
\begin{table}[h!]
\centering
\begin{tabular}{|c|c|c|}
\hline
\cellcolor{violet!60}\color{white}Location &
\cellcolor{violet!60}\color{white}Leads &
\cellcolor{violet!60}\color{white}Coronary artery \\
Anterior & V$_2$-V$_4$ & LAD \\
Lateral & V$_5$-V$_6$ & LCX > LAD \\
Inferior & II, III, aVF & RCA $\gg$ LCX \\
Posterior & V$_1$, V$_2$ (depression) & RCA $\gg$ LCX \\
\hline
\end{tabular}
\vspace{3mm}
\caption{ECG leads and arteries involved according to anatomical location of infarct}
\label{table:infarct-loc}
\end{table}

#### Reciprocal changes
- Acute STEMI in some surface of the heart $\rightarrow$ ST elevation in
 corresponding leads, and ST depression in reciprocal leads 

\renewcommand{\arraystretch}{1.5}
\rowcolors{2}{gray!20}{gray!40}
\begin{table}[h!]
\centering
\begin{tabular}{|c|c|c|}
\hline
\cellcolor{violet!60}\color{white}Site &
\cellcolor{violet!60}\color{white}Facing &
\cellcolor{violet!60}\color{white}Reciprocal \\
Septal & V$_1$, V$_2$ & V$_7$-V$_9$ \\
Anterior & V$_3$, V$_4$ & None \\
Lateral & I, aVL, V$_5$, V$_6$ & II, III, aVF \\
Inferior & II, III, aVF & I, aVF \\
Posterior & V$_7$-V$_9$ & V$_1$, V$_2$ \\
\hline
\end{tabular}
\vspace{3mm}
\caption{Reciprocal changes according to location of infarct}
\label{table:reciprocal}
\end{table}


\pagebreak

#### Evolution over time of the ECG appearance of STEMI
- STEMI = **complete proximal occlusion of major coronary artery**

\begin{figure}
\centering
\includegraphics[width=.5\textwidth]{../assets/med/STEMI.jpg}
\end{figure}


\begin{center}
$\fbox{A. Before the onset of infarction}$\\
$\downarrow$\\
$\fbox{B. In acute phase, ST elevation}$\\
$\downarrow$\\
$\fbox{C. Progressive loss of R and deepening Q}$\\
$\downarrow$\\
$\fbox{D. Resolution of ST elevation; fully developed pathological Q;
T inversion}$\\
$\downarrow$\\
$\fbox{E. In old infarcts, T-wave inversion may or may not persist}$\\
\end{center}


- ST elevation resolves after a few days

#### NSTEMI
- **Partial occlusion of major** or **complete occlusion of minor** coronary
 artery
- _Subendocardial/partial-thickness MI_ $\rightarrow$ **no pathological Q**
- **ST depression** + **T inversion** in chest leads

## Coronary Artery Disease
- Diseases arising due to narrowing of the lumen of one or more coronary
 arteries and the resulting ischaemia/infarction of the myocardium or
 the conductive system.
- **Types**:
	 - Stable angina: Fixed atheromatous stenosis
	 - Unstable angina:
	 	- dynamic obstruction
	 	- due to plaque rupture/erosion with thrombosis
	 - MI
	 - Heart failure
	 - Arrhythmia
	 - Sudden cardiac death
	 	- ventricular arrhythmia
	 	- asystole
	 	- massive MI

## Arrhythmias
### Antiarrhythmics
Discussed in Section \ref{sec:antiarr}

### Sinus arrhythmia
- Physiological alteration of HR with respiration
- Inspiration $\rightarrow$ $\uparrow$HR, expiration $\rightarrow$
 $\downarrow$HR (see also: Table \ref{table:haemo-resp})
- Absent in diabetic neuropathy

### Classification according to ECG morphology
- **Narrow complex**: QRS < 120ms (3 small sqs)
	- Sinus tachycardia
	- Atrial fibrillation (irregular narrow complex tachycardia)
	- Atrial flutter
	- AV Nodal Re-entry Tachycardia (AVNRT aka SVT)

- **Broad complex**: QRS > 120ms (3 small sqs)
	- Ventricular tachycardia
	- AV Re-entry Tachycardia (AVRT e.g. Wolff-Parkinson-White syndrome)
		- Abnormal band of conductive tissue connecting atria and ventricles
		 (accessory pathway)


### SVT (AVNRT)
#### Management
- **Carotid sinus massage** or
- **Valsalva** manoeuvre
- If the manoeuvre fails,
	- **Adenosine** (3-12mg IV) (see more in \hyperref[ssec:otheranti]{this
	 section}) or
	- Rate-limiting CCB (Verapamil 5mg IV) or
	- $\beta$-blocker
- If haemodynamic state compromised, **DC cardioversion**
- Recurrent SVT $\rightarrow$ catheter ablation

### Atrial flutter
#### Intro
- Caused by **macro re-entry circuit** usually in the rt atrium
- Atrial rate $\approx$ 300/min
- Because of the refractory period, not all of these 300 APs can excite
 the AV node $\rightarrow$ 2nd degree type II AV block (2:1, 3:1, or 4:1,
 corresponding to a ventricular rate of 150, 100, or 75/min)
- **Saw-tooth flutter waves** in ECG
- Dx confirmed if carotid sinus pressure / IV adenosine reveal flutter
 waves (by temporarily $\uparrow$ AV block)

#### Management
- Medical: digoxin, $\beta$-blockers, or verapamil
- DC cardioversion
- $\beta$-blockers or amiodarone to prevent recurrence
	- **Class Ic antiarrhythmics (e.g. flecainide) contraindicated**
		- Risk of facilitating 1:1 AV nodal conduction leading to extreme tachy
		 and haemodynamic compromise
- Catheter ablation
- Anticoagulant therapy (similar to \hyperref[item:anticoag]{A-fib's anticoagulant
 regimen})

### Ventricular tachycardia / VT
- Most commonly in acute MI, chronic CAD, cardiomyopathy
- Caused by abnormal automaticity in ischaemic tissue
- Features:
	- Palpitation
	- Dyspnoea
	- Lightheadedness
	- Syncope
	- Hypotension
	- Cardiac arrest
- **Management:** Prompt restoration of sinus rhythm by
- If systolic BP < 90 mmHg,  **DC cardioversion**
- Else, **IV $\boldsymbol\beta$-blocker / amiodarone**
	- If medical therapy fails, DC cardioversion

### Torsades de Pointes
- Form of **polymorphic VT** arising as a **complication of prolonged QT-
interval** (i.e. prolonged ventricular repolarisation)
- Literally, "twisting of the peaks" (French)
- QRS complexes "twist" around the isoelectric line

\begin{figure}[h!]
	\centering
	\includegraphics[width=.7\textwidth]{../assets/med/torsades.png}
	\vspace{4mm}
	\caption{Torsades de pointes}
\end{figure}

- Usually non-sustained, repetitive
- May progress to V-fib
- Causes of long QT (> 0.44s in men, > 0.46s in women)
	- Electrolyte imbalance
		- Hypo-K
		- Hypo-Ca
		- Hypo-Mg
	- Drugs
		- Class Ia, Ic antiarrhythmics (e.g. disopyramide, flecainide etc)
		- Class III antiarrhythmics (amiodarone, sotalol)
	- Congenital long QT syndrome
- **Management: IV Mg** 

## Atrial fibrillation
### Intro
- Most common sustained arrhythmia
- Associated with underlying heart disease, systemic embolism, stroke

### Causes
- **Cardiac**
	- CAD (including acute MI)
	- Mitral stenosis (MS; rheumatic mitral valve disease)
	- Hypertension
	- Cardiomyopathy
- **Non-cardiac**
	- Thyrotoxicosis
	- Pulmonary embolism
	- Pneumonia
	- Alcoholism

### Investigation
- ECG
- Echo: to see valvular condition
- Thyroid function test: to exclude thyrotoxicosis

### Management of AF
- **Rhythm control**:
	- **Pharmacological cardioversion**
		- Pt stable + no history of heart disease $\rightarrow$ **IV
		 flecainide**
		- Structural / ischaemic heart disease $\rightarrow$ **IV
		 amiodarone**
	- **DC cardioversion / catheter ablation** if drugs fail
- **Rate control:**
	- **Digoxin**
	- **$\boldsymbol\beta$-blockers**
	- **Rate-limiting CCB**: verapamil / diltiazem
- **Thromboprophylaxis:** \label{item:anticoag}
	- Oral **Warfarin**
	- Target INR: 2.0-3.0
	- Start 4wks before cardioversion, continue till 3mo after successful
	 cardioversion
	- **Monitor stroke risk by CHA$_2$DS$_2$-VASc score, and bleeding risk
	 by HAS-BLED score** (HAS-BLED $\ge$ 3 $\rightarrow$ close monitoring
	 on anticoagulant)
	- Directly acting oral anticoagulants (DOACs):
		- Factor Xa inhibitors: Rivaroxaban, apixaban, edoxaban
		- Direct thrombin inhibitors: dabigatran
		- Efficacy $\ge$ warfarin, haemorrhage risk, drug interactions
		 $\ll$ warfarin, effective antidote to manage acute bleed
		 (idarucizumab)
	- Avoid aspirin: little effect on embolic stroke, significant bleeding
	 risk

## AV block
### 1$^\circ$ AV block
- Prolonged PR interval (> 0.2s)
- Rarely symptoms; rarely need treatment

### 2$^\circ$ AV block
- **Dropped beats** i.e. not all impulses in the atria are conducted
 to the ventricles
- **Mobitz I:**
	- Progressively prolonging PR, then dropped beat, repeat
	- AKA **Wenckebach phenomenon**
	- Caused by disease in the AV node
- **Mobitz II:**
	- PR constant (when conducted), fixed proportion of atrial
	 impulses conduct to the ventricles (e.g. 3:1 block means for every 3
	 impulses coming from the atria 1 excites the ventricles)
	- Caused by disease in the His-Purkinje system
	- **Risk of asystole (cardiac arrest)**
- Impossible to distinguish type I and II in 2:1 block

### 3$^\circ$ AV block
- **AV dissociation**
- Causes:
	- MI
	- Infective endocarditis
	- Drugs: Digoxin, $\beta$-blockers, CCBs

### Features
- Recurrent syncope (**"Stokes-Adams"** attacks)
- Brief anoxic seizures

### Management
- Acute inferior MI often accompanied by AV block, as RCA supplies both
 the AV node and the inferior wall. Treat MI, no other treatment for AV
 block required.
- Symptomatic 2$^\circ$ and 3$^\circ$ block $\rightarrow$ atropine
- Asymptomatic 1$^\circ$ and 2$^\circ$ Mobitz I $\rightarrow$ no treatment
 required
- Mobitz II / 3$^\circ$ $\rightarrow$ permanent pacemaker (risk of sudden
 death from asystole)

## Antiarrhythmics
\label{sec:antiarr}

### Classification
#### By effect on the action potential
- Class I: Na$^+$-channel blockers (manipulate length of AP by controlling
 the refractory period)
	- Ia. Prolong AP: quinidine, disopyramide
	- Ib. Shorten AP: lidocaine, mexiletine
	- Ic. No effect on AP: Flecainide, propafenone
		- avoid if previous MI ($\uparrow$ risk of arrhythmia)
		- flecainide used in AF for rhythm control
			- may cause slow atrial flutter with rapid ventricular rate, so
			 prescribed with an AV-node blocking drug e.g. $\beta$-blocker
- Class II: $\beta$-blockers
	- reduce SA node firing rate
	- atenolol, metoprolol, bisoprolol
	- Uses:
		- Rate control in flutter and AF
		- Prevent recurrence of VT, SVT
- Class III:
	- amiodarone, dronedarone, sotalol
		- sotalol is a racemic mixture of l-sotalol (nonselective $\beta$-
		blocker) and d-sotalol (class III)
		- amiodarone also has I, II, IV activity
		- most effective drug in paroxysmal AF
	- prolong plateau phase $\rightarrow$ $\uparrow$refractory period
	- prolong QT-interval, may predispose to torsades de pointes / VT
- Class IV: rate-limiting CCBs
	- Verapamil, diltiazem
	- Uses: prevent SVT, rate control in AF

#### By site of action
\begin{figure}[h!]
	\centering
	\includegraphics[width=.7\textwidth]{../assets/med/antiarrhythmic.jpg}
	\vspace{4mm}
	\caption{Classification of antiarrhythmics by site of action}
\end{figure}

### Other antiarrhythmics
\label{ssec:otheranti}

- Atropine: in symptomatic / severe bradycardia
- Adenosine:
	- Mechanism: bind to A1 receptors in the AV node producing a
	 transient AV block for a few seconds, which terminates the
	 cyclical propagation of the impulse through the accessory
	 pathway
	- May cause bronchospasm $\rightarrow$ avoided in asthma
- Digoxin:
	- Slows conduction and prolongs AV node refractory period
		- So used for rate control in AF
	- Enhances conduction and shortens refractory period in other parts of
	 the heart $\rightarrow$ may promote atrial / ventricular ectopics

## Coronary artery disease
### Risk factors
- Smoking: most important modifiablle risk factor
- Age and sex:
	- Premenopausal women $\rightarrow$ $\downarrow$risk than men
	- Postmenopausal women $\rightarrow$ = risk as men
	- HRT in postmenopause $\uparrow$risk
- Diet:
	- $\downarrow$fruit, veg, PUFA $\rightarrow$ $\uparrow$risk



### Angina pectoris
#### Intro
- Chest pain due to transient myocardial ischaemia resulting from an
 imbalance between myocardial O$_2$ supply and demand

#### Pathogenesis
- Causes
	- Atherosclerosis
	- Coronary artery spasm
	- Syndrome X:
		- Effort angina + evidence of ischaemia on stress test + normal
		 arteries on angio
		- Mechanism unknown

#### Investigation
- **Exercise ECG: first line**
	- Planar / downsloping ST depression of $\ge$ 1mm indicates ischaemia
	- Upsloping ST depression nonspecific; may be nor	-mal
- Myocardial perfusion scan / stress echo: if exercise ECG inconclusive
- CT angiogram

#### Management
- **Lifestyle changes:**
\label{item:life}
	- Smoking cessation
	- Wt reduction
	- Regular exercise (up to, but not beyond, point of chest discomfort)
	- Sublingual GTN before exertion that may induce angina
- **Pharmacological therapy:**
	- Start with sublingual GTN + $\beta$-blocker
	- Add CCB or long-acting nitrate if needed
	- Statin, even if lipid profile normal
	- If 2$^\circ$ to CAD, antiplatelet therapy
		- Low-dose aspirin (75mg) / Clopidogrel (75mg) continued indefinitely
	- Sublingual GTN:
		- Relieve attack within 2-3 mins
		- Side effects:
			- Headache
			- Hypotension
			- Syncope
		- Continuous therapy may cause tolerance
			- Avoided by 6-8h nitrate free period, best achieved at night
			 as the patient is inactive
	- Beta-blockers:
		- Nonselective may aggravate vasospasm by blocking coronary arterial
		 $\beta_2$
		- So **once daily cardioselective $\boldsymbol\beta$
		 blocker** (metoprolol / bisoprolol)
		- Should not be withdrawn rapidly: $\beta$-blocker withdrawal syndrome
			- May precipitate arrhythmias, worsen angina, MI
	- CCBs:
		- Dihydropyridines (e.g. amlodipine) may cause reflex tach so combo
		 with $\beta$-blocker
		- Verapamil and diltiazem can be used as monotherapy as don't cause
		 tach
		- CCB $\rightarrow$ $\downarrow$contractility $\rightarrow$ used with
		 care if poor LV function
	- K-channel activators:
		- Nicorandil: only approved drug in this class
			- Vasodilator
			- No tolerance as with nitrates
	- I$_f$-channel antagonists:
		- Ivabradine:
			- Induces bradycardia
			- Doesn't inhibit contractility
			- Safe in heart failure
- **Nonpharmacological therapy**
	- PCI with / without stenting: if single or dual vessel disease
		- Restenosis is the main complication (in upto 1/3rd cases, usually
		 occurs within 3mo)
		- Prevented by stenting
		- Drug-eluting stents reduce risk further (antiproliferative drugs
		 e.g. sirolimus, paclitaxel prevent neo intimal hyperplasia)
	- CABG: if triple vessel disease



### Acute coronary syndrome (ACS)
#### Intro
- ACS = unstable angina or MI

#### Acute management
\begin{figure}
\centering
\includegraphics[width=.65\textwidth]{../assets/med/MI-mx.png}
\vspace{5mm}
\caption{Management of ACS}
\end{figure}

#### Long-term management
- **Lifestyle changes**: see \hyperref[item:life]{here}
- **2$^\circ$ prevention**
	- Antiplatelet therapy: aspirin and/or clopidogrel
	- $]beta$-blocker
	- ACEi / ARB
	- Statin
	- DM control
- If high-risk, ICD (implantable cardiac defibrillator)
 

#### Complications
- **Arrhythmias:**
	- Usually transient, no prognostic significance
	- VF is the major cause of death in those who die before receiving
	 medical care
	- Common arrhythmias in ACS
		- VF
		- V-tach
		- AF
		- A-tach
		- Accelerated idioventricular rhythm
		- Ventricular ectopics
		- Sinus bradycardia
		- AV block
- **Recurrent angina**
- **Acute heart failure**
- **Pericarditis**
- **Dressler's syndrome**
	- Fever, pericarditis, pleurisy
	- Probably autoimmune
	- If prolonged or severe, high dose aspirin, NSAIDs or glucocorticoids
- **Papillary muscle rupture**
	- Causes sudden severe MR, leading to the features
		- Acute pulmonary oedema
		- Shock
		- Pansystolic murmur radiating to axilla
	- Confirmed by echo
	- Emergency valve replacement
- **Ventricular septum rupture**
	- Presents with
		- Sudden haemodynamic deterioration
		- Pansystolic murmur: loud, radiating to rt sternal border
		- Acute RHF (due to lt to rt shunt)
	- Confirmed by Doppler echo and rt heart catheterisation
	- Emergency surgical repair
- **Ventricular rupture**
	- Usually fatal
- **Embolism**
- **Ventricular remodelling**
	- Thinning and expansion of infarct $\rightarrow$ $\uparrow$stress on
	 remaining ventricle $\rightarrow$ dilatation and hypertrophy of
	 remaining ventricle
	- ACEi and aldosterone antagonists reduce remodelling
- **Ventricular aneurysm**


## Heart failure
### Pathophysiology
\begin{figure}[h!]
	\centering
	\includegraphics[width=.9\textwidth]{../assets/med/hf-patho.jpg}
	\vspace{3mm}
	\caption{Neurohumoral activation and compensatory mechanisms in HF}
	\label{fig:hf-neuro}
\end{figure}

- Hazards of prolonged sympathetic stimulation
	- Cardiomyocyte apoptosis
	- Hypertrophy
	- Focal myocardial necrosis
	- Predispose to arrhythmias

### Causes
- **$\downarrow$ contractility**
	- MI
	- Dilated cardiomyopathy
	- Myocarditis
- **Outflow obstruction**
	- Systemic htn, pulmonary htn
	- Aortic stenosis, pulmonary stenosis
- **Inflow obstruction**
	- Mitral stenosis, tricuspid stenosis
- **Volume overload**
	- Aortic / mitral regurgitation
	- VSD
- **Arrhythmia**
	- A-fib
	- Tachycardia
	- Complete heart block
- **Diastolic dysfunction**
	- Constrictive pericarditis
	- Cardiac tamponade
	- Hypertrophic / restrictive cardiomyopathies
	- LVH and fibrosis

### Features
#### Acute LVF
- Sudden onset **dyspnoea** at rest
	- Progresses rapidly to respiratory distress, orthopnoea
- **Cool peripheries**
- **Rapid pulse**
- $\boldsymbol\uparrow$ **BP** (due to SNS activation)
	- May be low or normal if goes into cardiogenic shock
- $\uparrow$ JVP esp. if associated with fluid overload / RVF
- **Gallop rhythm** (tachycardia + 3 heart sounds (addition of S$_3$))
- **Bilateral basal crepitations** if pulmonary oedema

#### Chronic LVF
- Fatigue, $\downarrow$ effort tolerance: due to $\downarrow$ CO
- Cold peripheries
- $\downarrow$ BP
- Oliguria, uraemia: due to $\downarrow$ renal perfusion
- Pulmonary oedema
- Congestive cardiac failure: RVF + LVF (RVF 2$^\circ$ to LVF)
	- $\uparrow$ JVP
	- Ankle oedema (if ambulant) / sacral oedema (if bedbound)
	- Tender hepatomegaly
	- Ascites
	- Pleural effusion

### Complications
- Renal failure
- Hypo-K: due to
	- Treatment with loop / thiazide diuretics
	- Impaired aldosterone metabolism in congested liver
- Hyper-K: due to treatment with ACEi / ARB, K-sparing diuretics 
	(spironolactone, eplerenone)
- Hypo-Na:
	- Feature of severe HF; bad prognostic sign
	- Due to
		- Diuretic therapy
		- $\uparrow$ ADH secretion
- Impaired liver function: due to
	- Hepatic venous congestion
	- Poor perfusion
- Thrmboembolism
- Arrhythmias: due to
	- Electrolyte abnormalities (hypo-K, hypo-Mg)
	- Underlying cardiac disease
	- Sympathetic overactivity
- Sudden death: due to V-fib

### Investigation
- **CXR**
	- Distended upper lobe pulmonary veins
	- Lung fields plethoric
	- Bat-wing opacities (pulmonary oedema)
	- Septal / Kerley-B lines: horizontal lines in the costophrenic angles
	- Cardiomegaly (usually with chronic)
- **Echocardiography**
	- Detecting the aetiology
	- Assess the ejection fraction
	- Detecting asymptomatic valvular disease
- **BNP**
	- Elevated
	- Prognostic marker

### Management
#### Acute
- ALVF with pulmonary oedema is a medical emergency
- Continuous monitoring of ECG, BP, pulse oximetry
- Mnemonic: **SOPNiL**
	- **Sit** (propped-up position): $\downarrow$ preload
	- High-flow **O$_2$**: correct hypoxia
	- Ensure continuous +ve airway **pressure** (CPAP): $\downarrow$ preload
	- **Nitrates**: $\downarrow$ preload, afterload
	- **Loop diuretic**: correct fluid overload; $\downarrow$ preload
- If the above measures are ineffective, inotropes e.g. dobutamine.

#### Chronic
- **General measures**
	- Diet:
		- Wt reduction
		- Avoiding high salt intake
	- Cessation of alcohol consumption
	- Cessation of smoking
	- Moderate exercise within limits of symptoms
	- Consider influenza and pneumococcal vaccines
- **Drug therapy**
	- Diuretics
		- $\downarrow$ preload
		- Normally, reduced preload would reduce contractility as well,
		 but in HF, the myocardium is already beyond the maximum of
		 the Starling curve (i.e. preload vs contractility / CO)
	- ACEi / ARB:
		- Interrupt the vicious cycle of neurohumoral activation by
		 inhibiting RAAS (Fig. \ref{fig:hf-neuro})
	- Neprilysin inhibitors:
		- In resistant heart failure
		- Sacubitril is the only one available currently (in combo with
		 valsartan)
		- $\ominus$ Neprilysin $\rightarrow$ $\uparrow$ ANP, BNP
		 $\rightarrow$ diuresis, vasodilation
	- Vasodilators
		- If ACEi / ARB contraindicated (e.g. bilateral renal artery
		 stenosis)
		- Venodilators e.g. nitrates reduce preload
		- Arteriodilators e.g. hydralazine reduce afterload
	- $\beta$-blockers
		- Interrupt the vicious cycle of neurohumoral activation by
		 inhibiting SNS (Fig. \ref{fig:hf-neuro})
		- $\downarrow$ arrhythmia and sudden death risk
	- Ivabradine:
		- I$_{\text{f}}$ channel blocker
		- $\downarrow$ HR
	- Digoxin: rate control if coexisting A-fib
	- Amiodarone: if symptomatic arrhythmia present 
- **Non-pharmacological therapy**
	- Implantable cardiac defibrillators (ICD): improve prognosis if
	 symptomatic ventricular arrhythmias with HF
	- Resynchronisation devices (pacers): if marked conduction delay
	- Coronary revascularisation: CABG / PCI
	- Cardiac transplantation:
		- Most common indications: MI, DCM (dilated cardiomyopathy)
		- Reserved for young patients with severe disease despite optimal
		 therapy

## Peripheral artery disease (PAD)
### Pathogenesis
- Risk factors: same as CAD
- In developed countries, **almost all PAD is due to atherosclerosis**
- PAD in DM patients associated with severe limb ischaemia

### Features
- $\approx$ 25% symptomatic
- Symptomatic PAD affects legs 8x more commonly than arms
	- In leg, superficial femoral artery most commonly involved
	- In arm, subclavian artery most commonly involved
- **Intermittent claudication** (IC)
	- Most common symptom
	- Usually in calf muscles (as superficial femoral artery is the usual
	 site of pathology)
	- In thigh or buttock if iliac arteries involved
	- Pain comes on after walking upto a specific distance, rapid relief
	 on rest
- **Critical limb ischaemia**
	- Rest pain requiring opiate analgesia and/or ulceration or gangrene
	 present for > 2w, with ankle BP < 50mmHg
	- Rest pain with ankle BP > 50mmHg = SCLI (subcritical limb ischaemia)
	- Severe limb ischaemia = SCLI or CLI
	- IC usually due to single segment plaque, SLI always due to multilevel
	 disease
- **Acute limb ischaemia**
	- Due to acute thrombotic occlusion of stenotic segment /
	 thromboembolism
	- Features: **6P**
		- Pain
		- Pallor
		- Pulselessness
		- Perishing cold
		- Paraesthesia
		- Paralysis
	- Treatment:
		- Consult vascular surgeon
		- IV heparin bolus (3000-5000 U): limit thrombus propagation
		- Distinguishing thrombosis from embolism is difficult but
		 important as management different
		 	- Thrombosis: treat medically with heparin, antiplatelets,
		 	 statins
		 	- Embolism: urgent revascularisation within 6h (otherwise
		 	 extensive necrosis)
		- Irreversible ischaemia $\rightarrow$ amputation
- Features of chronic limb ischaemia
	- Pulses diminished / absent
	- Bruits
	- $\downarrow$temperature
	- **Buerger's sign**: pallor on elevation, rubor on dependency
	- Muscle wasting
	- Skin, nails: dry, thin, brittle
	- Loss of hair


### Investigation
- ABPI (ankle-brachial pressure index)
	- $\frac{\text{Systolic ankle BP}}{\text{Systolic brachial BP}}$
	- Normal: > 1, IC: 0.5-0.9, CLI: < 0.5
- Duplex scan
- CT / MRI with IV contrast
- Intra-arterial DSA (digital subtraction angiography): for those undergoing
 endovascular revascularisation
- Lipid profile
- Blood sugar

### Management
- Medical therapy:
	- **Smoking cessation**
	- **Regular exercise** (30 mins of walking, 3x a week)
	- **Antiplatelet** agents
		- Aspirin or clopidogrel (75 mg)
		- Newer drug: Voraxapar
			- Selective PAR-1 (proteasse-activated receptor 1) antagonist
			- Combo with aspirin or clopidogrel
	- **Statins**
	- **Cilostazol**:
		- peripheral vasodilator
		- improves walking distance
		- consider if nonresponsive to above
	- **Diagnose and treat DM, htn**, anaemia, HF
- Surgical therapy: if medical therapy outcome not good after 6mo
	- Angioplasty $\pm$ stenting
	- Endarterectomy
	- Bypass

## Buerger's and Raynaud's
### Buerger's
- Inflammatory disease of arteries distinct from atherosclerosis
- Usually in **young (20-30y) male smokers**
- Characteristically affects **distal arteries**
	- Claudication in the feet
	- Rest pain in the fingers / toes
	- Wrist and ankle pulses absent
	- Brachial and popliteal pulses present
- Treatment:
	- **Smoking cessation** often causes remission
		- Amputation usually needed if patient continues smoking
	- Vasodilators: **prostacyclin**
	- Sympathectomy

### Raynaud's
- **Young (15-30y) female in temperate climates**
- **Doesn't cause ulceration / infarction**
- Usually no significant pain
- Treatment:
	- Reassurance
	- Avoiding cold exposure
	- Nifedipine if symptoms troublesome


## Aortic diseases
### Aortic aneurysm
#### Intro
- Abnormal dilatation of aortic lumen
- Most common in infrarenal abdominal aorta
- Men : women = 3 : 1
- Typically in old (65-85y)
- In younger if associated with Marfan's

#### Pathogenesis
- Most common cause **atherosclerosis**
- Predisposing factors: DM, htn, hyperlipidaemia
- Tends to run in families
- Associated with **Marfan's** (autosomal dominant connective tissue disease)
	- Marfan's also associated with aortic dissection

#### Features
- Thoracic aortic aneurysms:
	- Acute severe chest pain
	- Features of AR
	- Compressive symptoms
		- Stridor
		- Hoarseness
	- Massive bleeding (if erodes into adjacent structure e.g. oeso or
	 bronchus)
- Abdominal aortic aneurysms:
	- Pain: central abdomen, back, loin, iliac fossa, groin
	- Thromboembolism
	- Compressive symptoms
		- Duodenal compression $\rightarrow$ obstruction, vomiting
		- IVC compression $\rightarrow$ leg oedema, DVT
	- Rupture 

#### Investigation
- **USG**: investigation of choice for dx
- **CT scan**:
	- more info about size and extent
	- standard pre-op investigation

#### Management
- **Surgical repair**
	- Open repair:
		- treatment of choice
		- replace aneursymal segment with prosthetic (Dacron) graft
	- Endovascular aneurysm repair (EVAR):
- If aneurysm is due to Marfan's, $\beta$-blockers
	- $\downarrow$ rate of dilatation, risk of rupture
- Rupture of the aneurysm mostly kills before reaching the hospital, so try
 preventing that
- Asymptomatic: Risks of surgery outweigh risks of rupture if $\le$ 5.5cm
- Symptomatic: All cases must be operated, as pain often predates rupture

### Aortic dissection
#### Intro
- Breach in arterial wall $\rightarrow$ blood enters media, splitting it
 into 2 layers (creating a false lumen)
- Men : women = 2 : 1
- Peak incidence: 6-7th decade
- Can occur in younger if associated with Marfan's, pregnancy, trauma

#### Pathogenesis
- **Risk factors**
	- Htn (in 80%)
	- Atherosclerosis
	- Coarctation
	- Genetic connective tissue disorders:
		- Marfan's
		- Ehlers-Danlos
	- Pregnancy (usually 3rd trimester)

#### Classification
- Important for management
- Based on **involvement of ascending aorta**
	- **Type A**
		- involves ascending aorta
		- 2/3rds of cases
		- may also extend into the descending
	- **Type B**: does not involve ascending aorta

#### Features
- **Pain**: **sudden, severe, "tearing"**
	- Type A: anterior chest pain
	- Type B: infrascapular back pain
- **Hypertension** unless major haemorrhage
- **Signs of AR**
- **Asymmetric pulses** (brachial, carotid, or femoral)
- Features due to **occlusion of aortic branches**
	- Coronary occlusion $\rightarrow$ MI
	- Carotid occlusion $\rightarrow$ stroke
	- Spinal artery occlusion $\rightarrow$ paraplegia
	- Renal artery occlusion $\rightarrow$ AKI
	- Limb occlusion $\rightarrow$ acute limb ischaemia
	- Mesenteric occlusion $\rightarrow$ gut ischaemia

#### Investigation
- **CT / MR angiography: investigation of choice**
- **CXR**
	- Broadened upper mediastinum
	- Distorted aortic knuckle
	- Lt sided pleural effusion

#### Management
- Initial management:
	- Pain control
	- Antihypertensive
- Definitive treatment:
	- **Type A:** emergency surgery to replace ascending aorta
	- **Type B:**
		- Treated medically ($\uparrow\uparrow\uparrow$ surgical risk)
			- Goal: maintain MAP (mean arterial pressure) at 60-75 mmHg
			- First line therapy: $\beta$-blocker (labetalol preferred for
			 additional $\alpha$-blockade)
			- If $\beta$-blockers contra $\rightarrow$ rate-limiting CCB
			 (verapamil, diltiazem)
			- If inadequate control Na-nitroprusside
		- Unless rupture / risk of rupture / vital organ ischaemia (gut /
		 kidney)

### Aortitis
- Syphilis is a rare cause
	- Characteristic saccular aneurysm of ascending aorta

### Marfan's
#### Intro
- **Autosomal dominant connective tissue disease**
- Mutations in gene FBN1 (codes for fibrillin: an ECM protein)

#### Features
- Aortic dissection
- Aortic aneurysm
- AR / MR
- Skin laxity
- Joint hypermobility
- Long arms, legs, fingers (arachnodactyly)
- Scoliosis, pectus excavatum
- High-arched palate
- Ocular abnormalities:
	- Lens dislocation
	- Retinal detachment

#### Investigation
- Genetic testing: confirmatory
- CXR: aortic dilatation
- Echo: valvular disease

#### Management
- $\beta$-blockers:
	- $\downarrow$risk of aortic dilatation
	- given in all Marfan's patients
- Avoid activities that raise cardiac output
- Surgical replacement or aortic root: if progressive dilatation

### Coarctation of the aorta
\label{ssec:coarc}

#### Intro
- **Mostly congenital, very rarely acquired**
- Male : female = 2 : 1
- Associated with:
	- Bicuspid aortic valve (normally, only mitral valve should be bicuspid,
	 all the others tricuspid)
	- Berry aneurysms in cerebral circulation

#### Pathogenesis
- Narrowing most commonly where the ductus arteriosus joins the aorta (just
 distal to the origin of the 3 main branches: brachiocephalic, lt common
 carotid, lt subclavian)
	- Proximal to narrowing (head & neck vessels) $\rightarrow$
	 $\downarrow$BP
	- Distal to narrowing $\rightarrow\;\downarrow$BP

#### Investigation
- **MRI: investigation of choice**
- CXR: may show changes in the contour of the aorta

#### Management
- Untreated $\rightarrow$ death due to
	- LVF
	- Aortic dissection
	- Haemorrhagic stroke
- **Surgical repair**:
	- Do in early childhood $\rightarrow$ no htn
	- Surgery done later $\rightarrow$ htn persists
- Balloon dilatation / stenting: if recurrence


## Hypertension
### Management
- **Lifestyle changes**
- **Drug therapy**:
	- Guidelines: figure \ref{fig:antihtn}
	- ACEi:
		- Use with care in **impaired renal function** or **bilateral renal
		 artery stenosis**
		- S/E:
			- 1st dose hypotension
			- Cough
			- Rash
			- Hyperkalaemia
			- Renal dysfn
	- CCB:
		- S/E of dihydropyridines (amlodipine/nifedipine):
			- Flushing
			- Palpitation
			- Fluid retention
		- S/E of verapamil: constipation

\begin{figure}[!h]
	\centering
	\includegraphics[width=\textwidth]{../assets/med/antihtn.png}
	\vspace{5mm}
	\caption{Antihypertensive therapy NICE guidelines}
	\label{fig:antihtn}
\end{figure}

## Acute rheumatic fever
### Intro
- Mainly in low- and mid-income countries
- Mainly affects children (5-15y)

### Pathogenesis
- Delayed immune response to group A strep infection (sore throat / skin inf)
- Anti strep-A cross-react with cardiac myosin and sarcolemmal membrane
 proteins $\rightarrow$ inflammation in the endo, myo, pericardium
- Also inflame joints by same mechanism
- Histology:
	- Fibrinoid degeneration in the collagen of connective tissue
	- **Aschoff nodules:** pathognomonic
		- **Only in the heart**
		- Multinucleated giant cells surrounded by macrophages, T cells

### Features
- **Revised Jones criteria**
	- **Major**
		- Carditis
		- Polyarthritis
		- Chorea
		- Erythema marginatum
		- Subcutaneous nodules
	- **Minor**
		- Fever
		- Arthralgia
		- $\uparrow$ ESR / CRP
		- Leucocytosis
		- 1$^\circ$ AV block
		- Previous rheumatic fever
	- **Supporting evidence**
		- Recent scarlet fever
		- $\uparrow$ ASO titre
		- +ve throat culture
- **$\boldsymbol\ge$ 2 major / (1 major + $\boldsymbol\ge$ 2 minor)**
 with supporting evidence
- Presumptive dx can be made without evidence of preceding strep inf if
 isolated chorea or pancarditis (if other causes excluded)
- **Carditis**
	- Manifestations:
		- Breathlessness (due to HF or pericardial effusion)
		- Palpitations
		- Chest pain (due to pan/pericarditis)
		- Pericardial friction rub (if pericarditis)
		- Soft pansystolic murmur (due to MR)
		- Soft mid-diastolic murmur (Carey Coombs murmur) due to valvulitis
		- AR (in 50% cases)
- **Arthritis**
	- **Asymmetric, migratory, involving large joints** typically knees,
	 ankles, elbows, wrists
	- Inflammation "migrates" from a joint within 1d - 4w
- **Skin lesions**
	- **Erythema marginatum**
		- In < 5% cases
		- Involves **trunk and extremities, not face**
	- **Subcutaneous nodules**
		- In 5-7% cases
		- Small (0.5-2cm), firm, painless, over extensor surfaces
		- Typically appear $\approx$ 3 wks after the onset of other
		 manifestations
- **Sydenham's chorea / St Vitus dance**
	- Usually appear $\ge$ 3mo after the episode, when all other
	 features may have disappeared
	- In $\approx$ 1/3rd cases, more in female
	- Spontaneous recovery within a few months

### Investigation
- Blood: CBC, ESR, CRP
- Throat culture
- ASO titre
- CXR: cardiomegaly, pulmonary congestion
- ECG: 1$^\circ$ AV block, features of pericarditis
- Echo: valvular disease

### Treatment
- Bed rest
- Antibiotics:
	- On dx: eliminate any residual strep infection by
		- IM benzathine benzylpenicillin (1.2M U, single dose) or
		- Oral phenoxymethylpenicillin (250mg qds 10d)
		- If penicllin allergy, erythromycin / cephalosporin
	- Long-term prophylaxis:
		- IM benzathine benzylpenicillin (1.2M U, monthly) or
		- Oral phenoxymethylpenicillin (250mg bds)
		- Continue for 5 yrs or until 21y age, whichever later
		- If residual heart disease, for 10 yrs or until 40y, whichever later
- Aspirin:
	- Relieves arthritis rapidly
	- Starting dose: 60 mg/kg 4hrly
	- Response within 24h helps to confirm dx
	- Continue until ESR falls
	- S/E:
		- Nausea
		- Tinnitus
		- Deafness
		- Vomiting
		- Tachypnoea
		- Acidosis
- Glucocorticoids:
	- More rapid symptomatic relief than aspirin
	- Use in carditis or severe arthritis
		

## Mitral valve disease
### Mitral stenosis
#### Pathophysiology
- **Almost always rheumatic**
- Valve orifice narrowed by **progressive fibrosis, calcification of
 leaflets**
- Dilatation and hypertrophy of LA
- $\uparrow$LA pressure $\rightarrow$ **pulmonary congestion, breathlessness**
- Progressive dilatation of LA commonly leads to **AF**
- Pulmonary htn may develop, protecting from pulmonary oedema, but leading
 to RVH, TR, RHF

#### Features
- Very slow progression
- **Exertional dyspnoea:** most dominant symptom
- **Fatigue** due to $\downarrow$ cardiac output
- **Acute pulmonary oedema** $\rightarrow$ haemoptysis
- **Thromboembolism** especially with AF
- Exam findings:
	- **Loud S$_1$**
	- **Tapping apex beat**
	- **Low-pitched mid-diastolic murmur** accentuated by exercise
	- Basal creps if pulmonary oedema

#### Investigation
- **Doppler echo: investigation of choice**
- **ECG:** AF, p-mitrale (bifid p-wave due to LA hypertrophy)
- **CXR:**
	- **Straight lt heart border**
	- **Double rt heart border**
	- **Widened carinal angle**
	- May be pulmonary congestion or oedema
- Cardiac catheterisation if valvuloplasty considered

#### Treatment
- **Medical:**
	- **Anticoagulation:** to $\downarrow$ thromboembolic risk
	- **Ventricular rate control:** digoxin, $\beta$-blockers, rate-limiting
	 CCB
	- **Diuretics:** to relieve pulmonary congestion
- **Valvuloplasty:**
	- **Treatment of choice if**
		- Significant symptoms
		- Isolated mitral stenosis with no/trivial mitral regurgitation
		- Mobile, non-calcified valve on echo
		- No thrombus in lt atrium
	- Procedure: illustrated in fig. \ref{fig:valvuloplasty}
	- Follow up yearly as risk of restenosis

\begin{figure}[!h]
	\centering
	\includegraphics[width=.5\textwidth]{../assets/med/valvuloplasty.jpg}
	\vspace{5mm}
	\caption{Mitral valvuloplasty}
	\label{fig:valvuloplasty}
\end{figure}

### Mitral regurgitation
#### Pathogenesis
- **Causes:**
	- **Rheumatic disease** is the main cause in countries where rheumatic fever
	 is common (causes damage to the valve cusps and chordae)
	- Mitral valve prolapse
	- Ischaemia or infarction of the papillary muscles
	- MI
	- Dilated cardiomyopathy
	- Endocarditis

#### Features
- **Breathlessness**
- **Fatigue**
- Oedema, ascites (if RHF)
- Palpitation (if AF)
- Exam findings:
	- **Soft S$_1$**
	- **Apical pansystolic murmur radiating to axilla**
	- Creps
	- $\uparrow$JVP

#### Investigation
- **Echo:** condition of wall and valves
- **Doppler:** quantify regurgitation
- **ECG:** AF due to atrial dilatation
- **CXR:**
	- Enlarged LA, LV
	- Pulmonary venous congestion
	- Pulmonary oedema

#### Management
- **Medical:**
	- Diuretics
	- Vasodilators if htn
	- Digoxin and anticoagulants if AF
- **Surgical valve repair:** treatment of choice for severe MR

## Aortic valve disease
### Aortic stenosis
#### Pathogenesis
- **Causes:**
	- Congenital AS
	- Calcification of congenitally bicuspid aortic valve
	- Rheumatic AS
	- Senile degenerative AS
- Stenosis $\rightarrow$ progressive LVH $\rightarrow$ angina (mismatch of
 myocardial demand and coronary arterial supply) $\rightarrow$ LVF
 $\rightarrow$ pulmonary oedema

#### Features
- **Cardinal symptoms: angina, breathlessness, syncope**
- Exam findings:
	- **Ejection systolic murmur** like "saw cutting wood"
	- **Slow-rising carotid pulse**
	- **Heaving apex beat** due to LV pressure overload
	- Narrow pulse pressure
	- Pulmonary oedema
- Asymptomatic for many years; deteriorate rapidly when symptoms develop
- Die within 5y of presentation if untreated

#### Investigation
- **Echo:** see ventricular wall, valve
- **Doppler:** severity of stenosis
- **ECG:**
	- LVH
	- "Strain" pattern: down-sloping ST segments and T-inversion in lateral
	 leads (due to LV fibrosis)
	- LBBB
- **CXR:** LV enlarged

#### Treatment
- Asymptomatic:
	- Conservative mx
	- Regular review with Doppler (yearly; if older, 6 monthly)
- Symptomatic:
	- Prompt **aortic valve replacement**
	- Delay $\rightarrow\;\uparrow$ risk of sudden death
	- Old age is not contraindication to surgery
	- **Balloon valvuloplasty:** if congenital AS
	- Anticoagulants if AF / if valve replacement with mechanical prosthesis

### Aortic regurgitation
#### Pathogenesis
- **Causes:**
	- Congenitally bicuspid aortic valve
	- Rhematic disease
	- Infective endocarditis
	- Trauma
	- Causes of aortic dilatation
		- Marfan's
		- Aneurysm
		- Aortic dissection
		- Syphilis
		- AnkSpond
#### Features
- Mild to moderate: asymptomatic, palpitations
- Severe: breathlessness, angina
- Exam findings:
	- **High volume/collapsing pulse**
	- $\uparrow$ pulse pressure
	- **Early diastolic murmur** best heard at **lt sternal edge**
	- **Soft mid-diastolic "Austin-Flint" murmur**: due to regurgitant jet
	 partly closing mitral leaflet (functional mitral stenosis)

#### Investigation
- **Doppler:** first choice
- **ECG:** LVH, T-inversion
- **CXR:** cardiomegaly, aortic dilatation, LVF
- Cardiac cath

#### Treatment
- Treat underlying disease (e.g. endocarditis / syphilis)
- Asymptomatic: annual follow up with echo
- **Valve replacement** if symptomatic
- Vasodilators if htn

## Tricuspid valve disease
### Tricuspid stenosis
#### Pathogenesis
- Usually rheumatic; almost always in association with mitral and aortic
 valve disease
- TS and TR may also occur in carcinoid

#### Features
- **$\boldsymbol\uparrow$JVP with prominent a wave**, slow y descent
- **Mid-diastolic murmur** best heard at **lower rt sternal edge**
	- Higher pitch than MS murmur
	- $\uparrow$ on inspiration
- RHF $\rightarrow$ hepatomegaly, ascites, peripheral oedema

#### Investigation
- **Doppler echo** confirms dx

#### Treatment
- Valvotomy / replacement
- Balloon valvuloplasty if isolated TS

## Pulmonary valve disease
### Pulmonary stenosis
- **Usually congenital**
- May occur with carcinoid syndrome
- Features:
	- **Ejection systolic murmur** loudest at **lt uppper sternal edge**
	 radiating to **lt shoulder**
	- **Wide split S$_2$**
	- May be thrill, best felt when leaning forwards, breathes out
	- RVH
- Investigation:
	- **Doppler echo:** definitive investigation
	- **ECG:** RVH
	- **CXR:** post-stenotic pulmonary dilatation
- Management:
	- Mild-moderate: no treatment required
	- Severe: balloon valvuloplasty / surgical valvotomy

## Prosthetic valves
- 2 types:
	- Mechanical: generate prosthetic heart sounds
	- Biological: generate normal heart sounds
		- Pig
		- Allograft
- **All mechanical valves demand long-term anticoagulation** as $\uparrow
 \uparrow\uparrow$ risk of systemic thromboembolism
- Biological valves in and of themselves don't raise the risk of thrombosis,
 but many undergoing valve replacement will need anticoagulation anyway
 for risk of recurrence of AF
- Mechanical valves more durable than biological

## Infective endocarditis
### Pathophysiology
- Typically at sites of pre-existing endocardial damage
- Common complication of IV drug use - Staph endocarditis of tricuspid valve
- Sites of endocardial damage attract platelets and fibrin $\rightarrow$
 vulnerable to colonisation by blood-borne organisms
- Avascular valve tissue and presence of fibrin and platelet aggregates help
 to protect proliferating microbes
- Vegetations (= microbes + fibrin + platelet) eventually grow large enough
 to cause obstruction/embolism

#### Microbiology
- $\ge$ 75% cases due to Staph or Strep
- Common cause of acute endocarditis:
	- _Staph aureus_ (most common)
	- _Strep pneumo_
	- _Strep pyo_
- Common cause of subacute endocarditis: Viridans strep (mitis, sanguinis)
	- oral commensals
	- may enter the bloodstream during chewing, brushing, or dental treatment
- Common cause of prosthetic valve endocarditis: coagulase -ve Staph e.g.
 _Staph epidermidis_
- _Enterococcus_, _Strep gallolyticus_ (aka _Strep bovis_) enter the blood
 from the bowel or urinary tract
	- Endocarditis caused by gallolyticus should be colonoscopied, as
	 gallolyticus associated with large gut cancer
- Gram -ve HACEK group cause 3-4% cases
- _Brucella_ endocarditis: history of cattle contact
- Fungal endocarditis: immunocompromised / indwelling catheter

### Features
- **Modified Duke criteria**
	- **Major**
		- Persistent +ve blood cultures >12h apart
		- $\ge 3$ +ve cultures over >1h
		- Vegetations on echo
		- New valvular regurgitation
	- **Minor**
		- Predisposing valvular / cardiac abnormality
		- IV drug abuse
		- Pyrexia > 38$^\circ$
		- Blood culture +ve but not reaching major criteria
		- Embolic disease
		- Vasculitic disease
	- **2 major / (1 major + 3 minor) / 5 minor** $\rightarrow$ definite
	 endocarditis
	- (1 major + 1 minor) / 3 minor $\rightarrow$ possible endocarditis
- Haematuria
- Heart failure
- New murmur
- Petechial rash
- Splenomegaly (if long-standing)
- Finger clubbing
- Splinter haemorrhage
- Osler's nodes:
	- Rare
	- Painful, tender fingertip swellings
	- Due to vasculitis
- Roth's spots on ocular fundus: rare

### Investigation
- **Blood culture and sensitivity**
- **Echo**
	- Transthoracic or transoesophageal (TOE)
	- TOE can detect vegetations as small as 1-1.5mm
- Urinalysis: proteinuria, microscopic haematuria
- ECG: AV block
- CXR: cardiomegaly, HF

### Management
- Prompt removal of any source of infection (e.g. tooth with apical abscess)
- **Antibiotic therapy:**
	- Subacute:
		- Withhold antibiotic treatment until C/S report
		- If empirical needed, **amoxicillin IV (2g 6x daily) with/without
		 gentamicin**
	- Acute:
		- Empirical with **vancomycin IV (1g bds) + gentamicin IV
		 (1mg/kg bds)**
	- Prosthetic valve endocarditis:
		- **Vancomycin IV (1g bds) + gentamicin IV (1mg/kg bds) + rifampicin
		 oral (300-600mg bds)**
	- Duration of therapy: 2w if fully susceptible strain
- Cardiac surgery with **debridement of infected material** and **valve
 replacement**, especially in those with _Staph aureus_ or fungal
 endocarditis


## Congenital heart disease
### Intro
- Maternal rubella associated with
	- PDA
	- PS
	- ASD
- Maternal alcohol abuse $\rightarrow$ septal defects
- Maternal lupus $\rightarrow$ congenital CHB (complete heart block)
- Central cyanosis if desaturated blood enters systemic circulation without
 passing through the lungs (rt to lt shunt)
- Prolonged cyanosis $\rightarrow$ finger / toe clubbing
- **Eisenmenger syndrome:**
	- Prolonged severe L2R shunt (e.g. VSD, PDA) $\rightarrow$ progressively
	 $\uparrow$ RV pressure $\rightarrow$ reversal of shunt (i.e. L2R becomes
	 R2L shunt)

### Patent ductus arteriosus (PDA)
#### Features
- Dyspnoea
- **Continuous "machinery" murmur** with late systolic accentuation, max in
 the lt 2nd ICS
- Thrill
- $\uparrow$ pulse volume
- May eventually progress to Eigenmenger's

#### Investigation
- **Echo: inv of choice**
- **ECG:** RVH
- CXR: enlarged pulmonary artery

#### Treatment
- Closure by **cardiac catheterisation with implantable occlusive device**
	- Done in infancy if significant shunt
	- Done in late childhood if smaller shunt (closure $\downarrow$
	 endocarditis risk)
- **Prostaglandin synthetase inhibitor (indomethacin / ibuprofen)** in the
 first wk of life to medically induce closure
	- If severe PS with L2R shunt thru ductus, ductus should be kept patent
	 until treatment to improve oxygenation

### Coarctation of the aorta
Discussed in subsection \ref{ssec:coarc}

### ASD
- Male:female = 1:2
- Most are ostium secundum defects involving fossa ovalis
- RA to LA shunt $\rightarrow$ gradual enlargement of rt heart
- Features:
	- Most asymptomatic for years, detected at routine exam / CXR
	- Dyspnoea
	- Chest infections
	- Heart failure
	- Arrhythmias esp. AF
	- Volume overload of RV $\rightarrow$
		- Wide fixed split of S$_2$
		- Systolic flow murmur over pulmonary valve
- Investigation:
	- **Echo:**
		- RV dilatation, hypertrophy
		- Pulmonary artery dilatation
	- **TOE:** precise size and location of defect
	- **CXR:** cardiomegaly, pulmonary plethora
	- **ECG:** incomplete RBBB
- Treatment:
	- If pulmonary flow $\ge$ 1.5x systemic flow, surgical closure /
	 cardiac catheterisation using implantable closure device
	- Else conservative treatment

### VSD
- **Most common congenital heart disease** (1/500 live births)
- Most commonly defect is at the junction between the muscular and membranous
 parts
- Features:
	- **Pansystolic murmur** best heart at **lt sternal edge** radiating
	 all over the precordium
	- Small VSD (maladie de Roger / Roger's disease) $\rightarrow$
	 loud murmur 
	- May progress to Eigenmenger's
- Investigation:
	- **Doppler:**
		- Helps to identify small defects that are likely to close
		 spontaneously
		- Larger defects:
			- Monitored with serial ECG and echo: see pulmonary htn signs
			- CXR: pulmonary congestion 
			- ECG: biventricular hypertrophy
- Treatment:
	- Small VSD $\rightarrow$ no treatment
	- Cardiac failure in infancy $\rightarrow$ digoxin, diuretics
	- Persistent failure / ECG/echo suggesting pulmonary htn $\rightarrow$
	 surgical repair
	- Eisenmenger:
		- Surgical repair contraindicated
		- Heart-lung transplant only effective treatment

## Myocarditis
### Causes
- Viral: most common
	- Coxsackie
	- Influenza A, B
- Bacterial:
	- _Borrelia burgdorferi_ (Lyme disease)
	- _Mycoplasma pneumoniae_
- Protozoal:
	- _Trypanosoma cruzi_ (Chagas')
	- _Toxoplasma gondii_
- Fungal: _Aspergillus_
- Parasitic: _Schistosoma_
- Drugs/toxins:
	- Alcohol, cocaine
	- Anthracyclines
	- Clozapine
	- Lithium
- Autoimmune:
	- SLE
	- RA
	- Systemic sclerosis
	- Sarcoidosis
	
### Features
- Self-limiting in most cases
- Death may be due to ventricular arrhythmia / rapidly progressive HF
	- Cause of sudden, unexpected death of young athletes
- Present in 4 varieties:
	- Fulminant: follows viral prodrome, results in severe HF / cardio shock
	- Acute
	- Chronic active
	- Chronic persistent

### Investigation
- Dx made after other common causes of cardiac dysfunction excluded
- **Echo:** LV dysfunction
- **Cardiac MRI:** myocardial inflammation
- Blood for tropo-I, tropo-T, creatine kinase

### Treatment
- Mainly supportive
- Treat HF and arrhythmia
- Avoid intense exertion (may induce fatal arrhythmia)
- Glucocorticoids / immunosuppressants don't help

## Cardiomyopathy
### Dilated cardiomyopathy (DCM)
#### Pathogenesis
- $\uparrow$LV mass with normal/reduced thickness
- $\ge 25\%$ are autosomal dominant
	- Mutations affecting myocyte cytoskeleton proteins (e.g. dystrophn,
	 lamin A and C, emerin, metavinculin)
- X-linked muscular dystrophies (e.g. DMD) are also associated with DCM
- Advanced HIV / Late autoimmune reaction to viral myocarditis may also
 cause DCM

#### Features
- Sporadic chest pain
- HF
- Arrhythmia
- Thromboembolism
- Sudden death

#### Investigation
- D/D includes ventricular dysfunction due to CAD. Dx DCM only after
 excluding CAD
- **Echo**
- **Cardiac MRI**
- Genetic testing if $\ge$ family members affected

#### Treatment
- Control HF
- Reduce risk of sudden arrhythmic death by $\beta$-blockers + ACEi/ARB

### Hypertrophic cardiomyopathy (HCM)
#### Intro
- **Most common form of CM** (1/1000)

#### Pathogenesis
- **Usually autosomal dominant**, high penetrance, variable expression
- Extensive LVH + myocardial fibrosis
- May be generalised or confined to the interventricular septum (asymmetric
 septal hypertrophy)
- Stiff Lv $\rightarrow\;\downarrow$impaired diastolic filling $\rightarrow$
 HF
- Septal hypertrophy $\rightarrow$ dynamic outflow tract obstruction
 (hypertrophic obstructive cardiomyopathy, HOCM)

#### Features
- **Very similar to AS, except jerky pulse in HCM**
- Angina on effort
- Breathlessness on effort
- Arrhythmia $\rightarrow$ sudden death (typically after vigorous exertion)
- **Most common cause of sudden death in young athletes**
- Heaving apex beat
- Double impulse at apex (palpable S$_4$ due to LA hypertrophy)
- MDM at base
- PSM at apex (due to MR)

#### Investigation
- **Echo: inv of choice**
- ECG: LVH
- Genetic testing

#### Treatment
- $\beta$-blockers, rate-limiting CCB, disopyramide: relieve symptoms,
 prevent syncope
- Amiodarone: control arrhythmia
- Relief of outflow obstruction by
	- Partial myectomy
	- Catheter ablation of basal septum
	- Avoid digoxin, vasodilators (may $\uparrow$ outflow obstruction)


## Cardiac tumours
- 1$^\circ$ cardiac tumours rare
- Most (75%) 1$^\circ$ are benign
	- Myxoma
	- Fibroma
	- Lipoma
	- Fibroelastoma
	- Haemangioma
- Atrial myxoma: most common in LA, treat by surgical excision

## Pericardial diseases
- Normal pericardial fluid: 50 mL
\vspace{-3mm}

### Acute pericarditis
#### Pathogenesis
- **Causes:**
	- Infection: viral, bacterial, tubercular
	- Inflammatory: RA, RF, SLE
	- Post-MI
	- Malignancy
- All forms may produce pericardial effusion
	- Haemorrhagic effusion $\rightarrow$ ca breast / bronchus / lymphoma

#### Features
- **Retrosternal chest pain**
	- Radiates to shoulders and neck
	- Aggravated by deep breathing, movement, change of posture, exercise,
	 swallowing
- **Low-grade fever**
- **Pericardial friction rub:**
	- Diagnostic of pericarditis
	- High-pitched, scratching / crunching noise
	- Typically during systole

#### Investigation
- Dx by features + ECG
- **ECG: ST-elevation with upward concavity** in leads over the affected area

#### Treatment
- Pain relief:
	- Aspirin (600mg, 6x daily)
	- Indomethacin (50mg tds)
- Viral pericarditis: recover within a few days/wks
- Purulent pericarditis: antibiotic therapy

### Pericardial effusion
#### Features
- Often accompanies pericarditis
- Quieter heart sounds
- Friction rub diminished in intensity
- Large / rapidly developing effusion $\rightarrow$ **cardiac tamponade**
 (acute HF due to compression)
 	- Dyspnoea
 	- $\uparrow\uparrow\uparrow$ JVP
 	- Kussmaul's sign: paradoxical $\uparrow$ JVP during inspiration
 	- Hypotension
 	- Tachycardia
 	- Pulsus paradoxus (abnormally large decrease in stroke volume, systolic
 	 blood pressure and pulse wave amplitude during inspiration. The normal
 	 fall in pressure is less than 10 mmHg.)
	- Oliguria

#### Investigation
- **Echo: inv of choice**
- CXR:
	- Enlarged cardiac silhouette
	- Large effusion $\rightarrow$ globular heart shadow

#### Treatment
- Large effusion causing tamponade (medical emergency) $\rightarrow$
 pericardiocentesis under echo guidance

### Tuberculous pericarditis
#### Treatment
- Anti-TB therapy + 3mo prednisolone course

### Chronic constrictive pericarditis
- Progressive thickening, fibrosis, calcification of pericardium
- Heart surrounded by solid shell $\rightarrow$ impaired filling

\vspace{-3mm}

#### Features
- S/S of systemic venous congestion
- Fatigue
- Rapid, low-volume pulse
- $\uparrow$JVP
- Kussmaul's sign
- Venouus congestion $\rightarrow$ hepatomegaly, ascites, peripheral oedema
- Pulsus paradoxus

#### Investigation
- CXR: pericardial calcification
- Echo
- CT scan

#### Treatment
- Diastolic HF $\rightarrow$ loop diuretics, aldosterone antagonists






\pagebreak


# Dermatology
## Anatomy and physiology
\begin{figure}
	\centering
	\includegraphics[width=.5\textwidth]{../assets/surg/skin-layers.jpg}
	\caption{Layers of the skin}
\end{figure}

- **Layers of skin**:
	- **Epidermis**: further layered into (from out$\rightarrow$in)
		- corneum
		- lucidum: _only in thick skin_ i.e. palm and sole
		- granulosum
		- spinosum
		- basale
	- **Dermis**: 
		- **Papillary dermis**: more superficial part, containing
			- loose areolar tissue
			- subpapillary vascular plexus
		- **Reticular dermis**: deeper part, containing
			- collagen
			- deep vascular plexus
			- nerves
			- pilosebaceous units (hair follicle + sebaceous gland)
			- sweat glands
			- some keratinocytes around the hair follicles and sweat glands
			 (important for wound healing - these are the reasons behind
			 healing without scarring in upto partial-thickness skin wounds)
	- Subcutis / subcutaneous tissue: (technically not part of the skin)
	 adipose tissue

### Epidermal appendages
- Hair follicles:
	- phases of growth
		- anagen: 
			- active growth
			- lasts years in scalp hairs
		- catagen: 
			- transitional
			- lasts days (in scalp)
		- telogen: 
			- resting
			- lasts months (in scalp)
- Sebaceous glands
	- usually associated with a hair follicle (called a _pilosebaceous
	 unit_)
	- $\fbox{androgens}\rightarrow$ **$\uparrow$** $\fbox{sebum}$
	- $\fbox{oestrogen}\rightarrow$ **$\downarrow$** $\fbox{sebum}$
- Sweat glands
	- innerved by _sympathetic cholinergic_ fibres

## Principles of management of skin disease
### Topical treatments
- Ointments vs Creams
	- Ointments preferred to creams for dry skin (e.g. chronic eczema) as
		- more hydrating
			- 80% oil + 20% water in ointments (vs 50-50 for creams) $\rightarrow$
		 	prevent water loss from skin by oil layer
		- less preservatives $\rightarrow$ less risk of allergy
- Emollients
	- Moisturise, lubricate, protect skin
	- _Vehicles without active drug_
- Gluocorticoids

### Phototherapy
- **UVB**
- **Psoralen UVA**
	- Psoralen:
		- natural photosensitiser from plant source
		- cross-link DNA strands on excitation with UVA
	- Cumulative exposure to PUVA $\rightarrow\;\;\uparrow$
	 risk of SCC, so reserved for UVB resistance
- Uses
	- Psoriasis
	- Atopic eczema
	- Vitiligo
	- Chronic urticaria

### Systemics
- Antihistamines
- **Retinoids**
	- _Anti-inflammatory_
	- Promote _differentiation of skin cells_
	- **Teratogenic**
		- must be prescribed with robust contraception
		- females must have negative pregnancy test before, during, and after
		 therapy
- **Immunosuppressants**
	- Glucocorticoids e.g. prednisolone
	- Methotrexate
	- Azathioprine

### Biologics
- Biological _inhibitors_ of _proinflammatory cytokines_
- **TNF-$\alpha$ inhibitors**
	- Infliximab
	- Etanercept
- **Interleukin inhibitors**
	- Ustekinumab: IL-12, 23
	- Guselkumab: IL-23
	- Secukinumab: IL-17
- _Rituximab_:
	- Binds to CD20 $\rightarrow$ cause ADCC of B cells
	- As terminally differentiated plasma cells don't have CD20 they're safe
	- Use: pemphigus vulgaris

### Non-surgical therapy
- **Cryo**
	- _Liquid N$_2$_
	- Causes cell membrane destruction $\rightarrow$ death
- Laser
- PDT / photodynamic therapy

## Skin cancers
### Classification
- Non-melanoma skin cancer (NMSC): most common
	- SCC
	- BCC
- Melanoma
	- Less common
	- More metastatic risk $\rightarrow$ cause of most skin cancer deaths


## Fungal infections
### Types
- Superficial
	- Dermatophytes: aka **ringworm / tineasis**
		- _Trichophyton_
		- _Epidermophyton_
		- _Microsporum_
			
	- Yeast
- Deep: less common
	- Chromomycosis
	- Sporotrichosis

## Scabies
### Agent
Caused by the mite _Sarcoptis scabies hominis_

### Diagnosis
- Identify the skin burrow 
- Visualize the mite by dermatoscope / extracting with a needle

### Treatment
- Affected + all asymptomatic family members / physical contacts
- Topical permethrin / malathion
	- 2 applications
	- 1 wk apart
	- Whole body, except head
- Oral Ivermectin:
	- Single dose
	- For poor adherence, immunosuppresion or heavy infestation


## Acne
- _Chronic inflammation_ of _pilosebaceous_ units

### Pathogenesis
Key components are:

- $\uparrow$ Sebum production
- Colonisation of pilosebaceous ducts by _Propionibacterium acnes_
- Occlusion of pilosebaceous ducts

### Features
- Hallmark: **comedone**
- Greasiness of skin

### Management
- **Mild disease**
	- Topical Benzoyl peroxide
	- Topical Retinoids
	- Topical antibiotics
		- Erythromycin
		- Clindamycin
- **Moderate disease**: topical _plus_
	- Systemic tetracycline
	- Oestrogen containing OCP
	- Isotretinoin: if inadequate response to topical+systemic therapy
	 for 6 months
- **Severe disease**
	- Isotretinoin 0.5-1 mg/kg for 4 months:
		- Reduce sebum secretion and follicle colonisation
		- Teratogen
		- Pregnancy must be avoided during treatment _and_ within 2 mo of
		 drug cessation
	- Systemic glucocorticoid (with isotretinoin)
	- If unable to use isotretinoin
		- UVB phototherapy
		- PDT

## Eczemas
- Seborrhoeic dermatitis is associated with _Malassezia_ yeasts

### Features
Most types have the following clinical features:

#### Acute
- Ill-defined erythema, oedema
- Papules, vesicles, bullae
- Exudation
- Scaling

#### Chronic
- Above features
- Lichenification
	- Skin thickening with pronounced skin markings, 2$^\circ$ to chronic
	 scratching
	- Fissures
	- Dyspigmentation

### Management
\begin{figure}[h!]
\centering
\includegraphics[width=.7\textwidth]{../assets/med/eczema.jpg}
\vspace{-10mm}
\caption{Management of eczema}
\end{figure}

\pagebreak

## Psoriasis
- Chronic inflammatory hyperproliferative skin disease
- **Characteristics**
	- **Well-defined erythematous scaly plaques**
	- Affecting **extensor surfaces, scalp, nails**

### Histological features
- Keratinocyte hyperproliferation + abnormal differentiation $\rightarrow$
 nucleated stratum corneum cells (transit time from basale to corneum reduced
 to 5 from 28 $\rightarrow$ keratinocytes reach the surface while immature)
- Inflammation with Th-1 and Th-17 infiltration
- Tortuosity of dermal capillaries and release of VEGF

### Exacerbating factors
- **Sunlight**
- **Trauma**
- **Infection**
	- $\beta$-haemolytic strep $\uparrow$ guttate psoriasis
	- HIV may initally present with severe psoriasis
- **Drugs**
	- Antimalarials
	- $\beta$-blockers
	- Lithium
	- NSAIDs
- **Stress and anxiety**

### Clinical types
- **Plaque** psoriasis:
	- most common
	- well-demarcated erythematous plaques
	- silver-white scales in untreated
		- bleed on scraping (due to dilated vessels underneath) $\rightarrow$
		 **Auspitz sign**
	- **Sites**
		- extensor surfaces
			- elbows
			- knees
			- lower back
		- scalp
		- nails
- **Guttate** psoriasis:
	- follows _Strep_ throat
	- common in children/adolescent
	- UVB highly effective
	- may herald the onset of plaque psoriasis in adulthood
- **Erythrodermic** sporiasis: generalised $\rightarrow$ medical emergency
- **Pustular** psoriasis

\pagebreak
### Management
\begin{figure}
\centering
\includegraphics[width=.7\textwidth]{../assets/med/psoriasis.jpg}
\caption{Management of psoriasis}
\end{figure}

### Complications
- Psoriatic arthropathy
- Exfoliative dermatitis
- Secondary infection
- Hyperuricaemia and gout

\pagebreak
## Hypopigmentation
### Causes
- Vitiligo
- Albinism
- Pityriasis alba
- Pityriasis versicolor

### Vitiligo
- **Acquired**
- Cell-mediated **autoimmune destruction of melanocytes**
- Loss of melanocytes $\rightarrow$ hypopigmented patches

### Albinism
- **Autosomal recessive**
- **Reduced melanin production** by **normal number of melanocytes**
- $\uparrow\uparrow$ risk of sunburn, skin cancer

## Hyperpigmentation
### Causes
- **Endocrine**
	- Melasma/chloasma:
		- in pregnancy / some OCP users
		- discrete patches of facial pigmentation
	- Addison's disease
	- Cushing's syndrome
	- Nelson's syndrome
		- hyper-ACTH 2$^\circ$ to bilateral adrenalectomy for Cushing's
		- due to loss of -ve feedback from plasma cortisol
	- CKD
- **Drugs**
	- Amiodarone
	- Anti-cancers:
		- Bleomycin: Hodgkin's
		- Busulfan: CML
	- Choroquine
	- Psoralens


## Stuff not large enough to devote a section to
### SPF (sun protection factor)
- $\frac{\LARGE{\text{UV dose for producing erythema with sunscreen}}}
{\LARGE{\text{UV dose for producing erythema without sunscreen}}}$

### Mechanism of venous ulceration
\begin{center}
\fbox{Incompetent valves} \\
$\downarrow$ \\
\fbox{$\uparrow$ capillary pressure} \\
$\downarrow$ \\
\fbox{Fibrinogen leaks out of capillary} \\
$\downarrow$ \\
\fbox{Forms fibrin clot around capillary (pericapillary cuffing)} \\
$\downarrow$ \\
\fbox{Impaired diffusion from capillaries} \\
$\downarrow$ \\
\fbox{Impaired oxygenation}
\end{center}


\pagebreak

# Nephrology
## Anatomy and Physiology
### Nephron
- **Glomerulus** (fig. \ref{fig:glomerulus})
	- Glomerular capillaries enclosed by Bowman's membrane
	- Space between adjacent capillaries occupied by _mesangial cells_
	- **Glomerular capillaries:**
		- Endothelial cells with
			- fenestrations ($\approx$ 70nm)
			- charged glycocalyx (mostly -ve)
		- GBM (glomerular basement membrane) made of _type IV collagen_ etc
	- **Podocytes / visceral epithelial layer:** interdigitating foot
	 processes cover up the fenestrations, making the filtration barrier
	 tighter
	- **Mesangial cells:**: contract and relax to control
	 capillary diameter $\rightarrow$ GFR
- **Renal tubules**
	- Lining different according to location and function
	- **Interstitial fibroblasts** produce **erythropoietin**

### Juxtaglomerular (JG) apparatus
- **Macula densa** around the distal tubules: Sense Na concentration in
 distal tubule filtrate, controlling the **tubuloglomerular feedback**
 mechanism
 
	- If low GFR, release PGE2 $\rightarrow$ dilate afferent arteriole
	 $\rightarrow$ $\uparrow$GFR
	- If high GFR, make adenosine from ATP $\rightarrow$
	 afferent arteriolar constriction $\rightarrow$ $\downarrow$GFR
		- Aside: this is the mechanism behind the mild diuresis
		 produced by caffeine. Adenosine carries the signal for
		 tiredness in the brain, and caffeine blocks adenosine receptors.
		 In the brain, the blocking means you feel less tired. In the
		 afferent arterioles, blocking means you can't reduce your GFR. 
	- If high GFR, stimulate **JG cells** to secrete renin

\begin{figure}[h!]
	\centering
	\includegraphics[width=.7\textwidth]{../assets/med/glomerulus.jpg}
	\caption{Microstructure of the glomerulus}
	\label{fig:glomerulus}
\end{figure}


## Presenting problems in urinary disease
- **Oliguria:** < 400mL/day
- **Anuria:** < 100mL/day
- **Haematuria:**
	- Healthy indiviuals may have upto 12,500 RBCs/mL
	- Macroscopic or microscopic-dipstick+ haematuria indicates significant
	 pathology
	- **Types:**
		- Initial: 
			- blood during the start of micturition
			- cause: penile urethral pathology
		- Terminal:
			- blood at the end of micturition
			- cause: bladder / prostatic urethral pathology
		- Intermittent:
			- cause: IgA nephropathy, Alport's, PKD, renal tumour
- **Proteinuria:**
	- **Very small amounts of high molecular weight** and **moderate
	 amounts of
	 low molecular weight proteins pass through the healthy GBM** (glomerular
	 basement membrane)
	- Whatever passes is **almost completely reabsorbed** by receptors
	 on tubular
	 cells
	- So in healthy individuals, < 150mg/day protein excreted through urine
	- Transient proteinuria
		- Causes
			- Vigorous exercise
			- Fever
			- Heart failure
			- UTI
		- Retest after trigger has resolved to verify if persistent
		 proteinuria
	- Proteinuria best tested on early morning sample, as some have
	 orthostatic proteinuria (benign, < 1g/day, associated with upright
	 posture)
	- Dipstick positive when > 0.5 g/day
		- If persistent dipstick proteinuria, 24h urinary protein must
		 be quantified. > 1g/day $\rightarrow$ likely glomerular disease
		- PCR (Protein:Creatinine ratio) in spot sample might give better
		 estimates than 24h protein as 24h urine collection is often inaccurate
		- Renal biopsy to confirm dx in significant proteinuria
		
## Glomerular diseases ("Glomerulonephritides")
### Introduction
- Though strictly means inflammation of the glomeruli, used to describe
 all glomerular disease (even if non-inflammatory e.g. minimal change 
 disease)
- Lie on a _spectrum_, from _nephrosis_ (podocyte pathology $\rightarrow$
 proteinuria) to _nephritis_ (inflammation + GBM damage $\rightarrow$
 haematuria)

### Types
#### Nephrotic presentation
- **Minimal change disease**
	- Normal except on electron microscopy
	- Electron microscopy shows fusion of podocyte foot processes
- Focal segmental glomerulosclerosis (FSGS)
- **Membranous nephropathy**

#### Mild glomerulonephritic presentation
- IgA nephropathy
- Mesangiocapillary glomerulonephritis

#### Rapidly progressive glomerulonephritic presentation
- Focal necrotising glomerulonephritis
- Diffuse proliferative glomerulonephritis
- Anti-GBM disease (aka Goodpasture's syndrome)


\section[Nephrotic syndrome]
{Nephrotic syndrome
\footnote{
Most parts of this section, unless specifically
mentioned to be for membranous nephropathy, refers to minimal
change disease i.e. (most cases of) paediatric nephrotic
syndrome}}

### Features
- Massive **proteinuria** (> 3.5 g/day (medicine) or 1 g/m$^2$/day (paediatrics))
	- **Hypoalbuminaemia** (< 3 g/dL)
	- Generalised **oedema** (pitting)
	- "Effusions": Ascites, pleural effusion, pericardial effusion
- Features of reduced circulatory volume
	- Scanty urination (colour normal)
	- Pulse: weak
	- BP: low
	- Capillary refill: prolonged (> 3s)
- Hyperlipidaemia & lipiduria
	- due to $\uparrow$ lipoprotein production by liver
- **Recurrent infections**
	- due to loss of immunoglobulins with urine
- Features of **complications**
	- Shiny abdominal wall, rigidity and tenderness, absent bowel sounds
	 $\rightarrow$ **peritonitis**, likely by _Strep pneumo_
	- Loin pain $\pm$ palpable kidney + haematuria $\rightarrow$ **renal
	 vein thrombosis**
	- Alterations of consciousness, hemiplegia $\rightarrow$ **stroke** 

### Histopathology
- Histological types include
	- **Minimal change disease:**
		- no pathology visible with light microscope,
		 visible pathology only under electron microscope.
	 	- most common type in **children** (2-8y)
	- **Membranous nephropathy:** most common type in **adults**


### Aetiopathogenesis
\begin{figure}[h!]
	\centering
	\begin{subfigure}{.45\textwidth}
		\includegraphics[width=\textwidth]{../assets/med/nephrotic-mcd.png}
		\caption{Minimal change disease}
	\end{subfigure}\hfill
	\begin{subfigure}{.45\textwidth}
		\includegraphics[width=\textwidth]{../assets/med/nephrotic-mn.png}
		\caption{Membranous nephropathy}
	\end{subfigure}
	\vspace{5mm}
	\caption{Pathogenesis of nephrotic syndrome}
\end{figure}

#### Minimal change disease
- **Effacement of podocyte foot processes**

#### Membranous nephropathy
- **Autoantibodies to podocyte surface antigens** (e.g. M-type phospholipase
 A$_2$ receptor 1)$\rightarrow$ **MAC-mediated glomerular capillary injury**
 	- Antibodies to phospholipase A$_2$ (PLA2Rab), thus, can be used for
 	 diagnosis without biopsy (but may be absent in early disease so biopsy
 	 might still be needed)
- **Aetiology:**
	- Primary / Idiopathic: HLA-DQA1
	- Secondary:
		- Drugs e.g. NSAIDs, penicillamine (treatment for Wilson's)
		- Heavy metal poisoning
		- Hep-B
		- Malignancy
		- SLE
- Fates:
	- 1/3 spontaneous remission
	- 1/3 remain nephrotic
	- 1/3 progressive CKD


### Investigation
- Urine RME
	- Albuminuria
	- Granular & hyaline casts
	- Pus cells if associated with UTI
- Diagnostic
	- 24h total protein: > 1g/m$^2$/day
	- PCR (Protein-Creatinine ratio) > 2 
	- Serum albumin < 25 g/L
	- Serum cholesterol > 220 mg/dL
- Renal biopsy: if nonresponsive to corticosteroid therapy

### Treatment
#### Minimal Change Nephropathy
- **Specific:**^[https://kdigo.org/wp-content/uploads/2017/02/KDIGO-GD-Guideline-Key-Takeaways-for-Clinicians-Nephrotic-Syndrome-in-Children.pdf]
	- **High dose glucocorticoid for 6wks**
	- Prednisolone 1 mg/kg/day
	- KDIGO guidelines: (4wks daily + 4wks alternate day) or
	 (6wks daily + 6wks	 alternate day)
	- Incomplete response to steroid: Cyclophosphamide (1.5-2 mg/kg/day)
	 or Ciclosporin (3-5 mg/kg/day) for
	 8-12wks with prednisolone 7.5-15 mg/day (i.e. low dose)
- **Supportive:**
	- Diet:
		- normal with adequate protein
		- salt restriction
	- Oedema: if severe,
		- restrict salt and fluid intake
		- loop diuretics
	- Hypovolaemia: infuse albumin
	- Infections: treat & prevent (pneumococcus, meningococcus vaccine)
	- Hypercoagulability: 
		- due to loss of coagulation inhibitors (antithrombin III, protein C,
		 protein S) + $\uparrow$ liver production of procoagulants
		- consider LMW heparin / warfarin if severe NS


#### Membranous Nephropathy
- **Specific:**^[https://kdigo.org/wp-content/uploads/2017/02/KDIGO-GD-Guideline-Key-Takeaways-for-Clinicians-Membranous-Nephropathy.pdf]
	- **High-dose glucocorticoids + cyclophosphamide** (Ponticelli regimen)
		- Reserved for severe cases for risk of toxicity of this regimen
	- If secondary,  **treat the underlying cause**
- **Supportive:** same as above

### Complications
- Hypercoagulability $\rightarrow$ **renal vein thrombosis**, **pulmonary
 embolism**
 	- Dx of RVT: Doppler, CT, or MRI
 	- Rx: Heparin 6 days (5-7d), Warfarin 6 months (3-6m)
- Infections: due to loss of immunoglobulins
	- **Pneumococcal infection** $\rightarrow$ peritonitis, septicaemia
	- Cellulitis
	- Strep infection
- Hyperlipidaemia $\rightarrow$ **atherosclerosis**
- **Pleural effusion**
- **Pericardial effusion**


## Acute post-streptococcal glomerulonephritis
### Pathogenesis
- Occurs following sore throat or skin infection by **group-A
 $\boldsymbol\beta$-haemolytic
 streptococcus** (nephritogenic strains: 12, 49)
- **Antibodies against streptococcal M protein cross-react** with
 glomerular antigens because of molecular mimicry
- Complement activation, inflammatory cell infiltration. Net effects:
	- **Oliguria**
	- **Haematuria**
	- Hypervolaemia, **hypertension**, hyperkalaemia
	- **Oedema**
	- **$\downarrow$ Renal function** $\implies$
		- Azotaemia
		- Acidosis
- **Complications** (due mostly to acute hypertension)
	- Acute LVF
	- Hypertensive encephalopathy
	- Acute kidney injury

### Features
- Age: 5-12y; history of strep throat/skin infection a few wks prior
- **Scanty, smoky urine**
- **Puffy face**
- **Hypertension**
- Features of _complications_
	- $\fbox{ALVF}$:
		- cough
		- respiratory distress
		- orthopnoea
		- gallop rhythm
		- bilateral basal crepitations
	- $\fbox{Hypertensive encephalopathy}$:
		- headache
		- blurred vision
		- convulsion
		- delirium
		- papilloedema
	- $\fbox{AKI}$: anuria

### Investigation
- **Evidence of nephritis**
	- Urine RME:
		- RBC, RBC casts
		- Mild proteinuria
		- Leucocytes
	- Serum C3: $\downarrow$
	- Serum C4: normal
- **Evidence of prior strep infection**
	- ASO titre: $\uparrow$
	- Anti-DNAse B: $\uparrow$
- **Evidence of complications**
	- Serum electrolytes: may show hyperkalaemia and acidosis
	- Serum creatinine
	- X-ray chest

### Treatment
- **Rest**
- **Diet**: restrict fluid, salt, protein.
- **Diuretics**: furosemide
- **Antibiotics**: phenoxymethyl penicillin PO to prevent spread of
 remaining strep within the body
- **Antihypertensive**

\pagebreak

## Alport's syndrome
- Mutation / deletion of COL4A5 on chr-X $\rightarrow$ **defect of collagen
 type IV**
- **X-linked recessive**
- $\fbox{Deposition of abnormal collagen}\;\rightarrow\;
	\fbox{progressive degeneration of GBM}$
	 - Haematuria starts in early infancy
	 - ESRD by late teens / twenties
	 - Female carriers usually have haematuria, rarely significant
	  renal disease
- Other basement membranes with collagen IV are also involved
	- cochlear BM $\rightarrow$ **SNHL** (sensorineural hearing loss;
	 especially in high-frequencies)
	- **ocular abnormalities**:
		- lenticonus
		- keratoconus
		- cataracts
		- corneal erosions
- ACEi may slow (but not prevent) loss of renal function
- Might require RRT (renal replacement therapy)


## Adult Polycystic Kidney Disease
### Introduction
- Better known as Autosomal Dominant PKD (ADPKD)
	- There's a much rarer (1:20,000) autosomal recessive PKD (ARPKD)
- Prevalence 1:1000
- **Autosomal dominant**
- Small cysts lined by tubular epithelium develop from childhood, enlarge
 slowly
- Surrounding normal kidney tissue compressed and progressively damaged
- Mutations: PKD1 (in 85%), PKD2 (15%) (code for polycystin 1 and 2,
 respectively)

### Features
- Asymptomatic initially
- **Hypertension** from around 20 yrs of age
- Either (or both) kidney may be palpable, nodular
- Vague **loin discomfort** due to **enlarging mass**
- Acute loin pain due to haemorrhage into a cyst
- **Haematuria** with little / no proteinuria
- About 30% have **hepatic cysts** (mostly with no liver function impairment)
- **Berry aneurysms** of cerebral vessels in $\approx$ 5% (may lead to SAH)
- **Renal failure** $\rightarrow$ features of CKD
- Mitral / aortic regurgitation (frequent, rarely severe)

### Investigation
- Dx is based on family history, clinical features, and USG
- Criteria for dx in patients with +ve family history
	- 15-39y: $\ge$ 3 unilateral or bilateral cysts
	- 40-59y: $\ge$ 2 cysts in each kidney (total: $\ge$ 4)
	- $\ge$ 60y: $\ge$ 4 cysts in each kidney (total: $ge$ 8)

### Management
- **BP control:** 1st choice ACEi / ARBs
- **Tolvaptan:** Vasopressin V2 receptor antagonist
	- Reduce cyst growth
	- Slow rate of GFR decline
- **Octreotide:** Long acting somatostatin (aka growth hormone inhibiting
 hormone) analog
	- Reduces rate of growth of liver and renal cysts
- **Large cyst: US-guided aspiration / laproscopic cystectomy**
- **RRT** (renal replacement therapy) **:** dialysis /  transplantation

\pagebreak

## Renal artery stenosis
### Introduction
- **Most common cause of 2$^{\circ}$ hypertension**
- Most cases are due to **atherosclerosis**
- Younger ($\le$ 40) cases mostly non-atheromatous, due to _fibromuscular
 dysplasia_

### Pathophysiology
\begin{center}
\begin{tikzpicture}[
	FCT/.style={rectangle, draw=red!60, fill=red!5, very thick, minimum size
	=5 mm},
]
$\node[FCT] (Sten) {Renal artery stenosis};$
$\node[FCT] (Perf) [below=of Sten] {$\downarrow$ Renal perfusion pressure};$
$\node[FCT] (RAAS) [below=of Perf] {$\bigoplus$ Renin-angiotensin system};$
$\node[FCT] (Vasocons) [below left=25mm of RAAS, xshift=25mm] {Vasoconstriction};$
$\node[FCT] (Aldo) [below right=25mm of RAAS, xshift=-30mm] {$\uparrow$ Aldosterone production};$
$\node[FCT] (htn) [below=40mm of RAAS] {2$^{\circ}$ hypertension};$

$\draw[-{Stealth[length=5mm]}, very thick] (Sten.south) to node[right] {} (Perf.north);$
$\draw[-{Stealth[length=5mm]}, very thick] (Perf.south) to node[right] {} (RAAS.north);$
$\draw[-{Stealth[length=5mm]}, very thick] (RAAS.south) to node[right] {} (Vasocons.north);$
$\draw[-{Stealth[length=5mm]}, very thick] (RAAS.south) to node[right] {} (Aldo.north);$
$\draw[-{Stealth[length=5mm]}, very thick] (Vasocons.south) to node[right] {} (htn.north);$
$\draw[-{Stealth[length=5mm]}, very thick] (Aldo.south) to node[right] {} (htn.north);$

\end{tikzpicture}
\end{center}

### Features
- Hypertension: may be severe and difficult to control
- Acute pulmonary oedema: associated with severe hypertension
- Progressive renal failure
- Worsened renal function with ACEi or ARB administration ($\ge$ 30%
 increase in serum creatinine raises possibility of renal artery
 stenosis)
- Peripheral vascular disease: associated, but not caused by the stenosis
	- In older patients with atherosclerotic renal artery stenosis
	 (due to generalised atherosclerosis)
	- Especially in legs

### Investigation
- CT / MR angiogram of renal vasculature: confirmatory
- Serum creatinine: to see if worsening renal function
- Plasma renin: may be elevated
- Serum electrolytes: may be hypokalaemia due to hyperaldosteronism
- USG: asymmetrically sized kidneys

### Treatment
#### Medical
- Antihypertensives: not ACEi or ARB
- Lipid-lowering agents: Statins
- Anti-platelets: Low-dose aspirin 

#### Surgical
- Angioplasty
- Indications:
	- $\le$ 40y age
	- BP not controlled by antihypertensive / history of malignant htn
	- History of flash pulmonary oedema
	- Deteriorating renal function

## Thrombotic microangiopathies (HUS, TTP)
### Introduction
- Thrombotic occlusion of arterioles and capillaries especially in
 the kidneys or brain
- Common feature of these is **microangiopathic haemolytic anaemia (MAHA)**
	- Haemolysis due to passage of RBCs through abnormal vessels
	- **Schistocytes** (fragmented RBC) may be seen on PBF
	- **Reticulocytosis**
	- **$\uparrow$ unconjugated bilirubin, serum LDH**
	- **$\downarrow$ serum haptoglobin**
		- Lysed RBCs release free Hb into the bloodstream. This can enter
		 into tissues and trigger the inflammatory cascade, leading to
		 tissue damage. To protect from this, the body comes equipped with
		 a plasma protein called _haptoglobin_, which binds to free Hb.
		 When there's intravascular haemolysis, free Hb is released, and
		 haptoglobin is used up, leading to its decreased serum levels.

### Haemolytic uraemic syndrome
- Thrombotic microangiopathy predominantly involving renal microcirculation
- Cause: **shiga-like toxin producing bacteria**
	- Enterohaemorrhagic _Escherichia coli_
	- _Shigella dysenteriae_
- Most common cause of AKI in children
- If no bloody diarrhoea, atypical causes of HUS (e.g. complement system
 abnormalities - familial HUS) should be considered

### Thrombotic thrombocytopoenic purpura
- Thrombotic microangiopathy predominantly involving cerebral
 microcirculation
- MAHA + thrombocytopoenia
- Autoimmune: antibodies to ADAMTS-13
	- aka vWF cleaving protease
		- functions of vWF: haemostasis (thrombus + clot)
			- bind to and stabilize Factor VIII (unbound half-life: 1h,
			 bound to vWF: 12h)
			- help platelet aggregation
	- destruction of ADAMTS-13 $\rightarrow\;\;\uparrow$ vWF $\rightarrow$
	 thrombosis

## Acute kidney injury (AKI)
### Definition
- Sudden, (usually) reversible loss of renal function, developing over
 days or weeks (**< 3 months**), evidenced by rising serum creatinine
 and / or falling GFR.
- KDIGO criteria^[
	https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-Guideline-English.pdf
]: presence of any of the following
	- _$\Delta$SCr $\ge$ +0.3 mg/dL over 48h_
	- _$\Delta$SCr $\ge$ +0.5x baseline_ \scriptsize (or SCr $\ge$ 1.5x baseline)\normalsize\ 
	_over 7d_
	- _Urine volume $\le$ 0.5 mL/kg/h for $\ge$ 6h_

### Causes
#### Pre-renal
- Cardiac failure
- Blood loss
- Dehydration
- Burns
- Sepsis

#### Renal
- _AGN_ (acute glomerulonephritis)
- _AIN_ (acute interstitial nephritis)
	- Drugs (more in \hyperref[ssec:aki-feat]{Features})
	- Toxins
	- Inflammatory disease
	- Infection
- _ATN_ (acute tubular necrosis)
	- Drugs
	- Toxins
	- Prolonged hypotension

#### Post-renal
- Bilateral renal stone
- BEP (benign enlargement of prostate)
- Bladder / prostate / cervical cancer
- Urethral stricture
- Meatal stenosis
- Phimosis

### Features
\label{ssec:aki-feat}

- Pre-renal: features of shock
- Renal: 
	- AGN: haematuria, mild proteinuria, oedema, htn
	- AIN: worsened renal function following drugs (_NSAIDs_, PPIs,
	penicillins)
	 	- NSAIDs $\rightarrow\;\;\downarrow$ prostaglandins $\rightarrow$
	 	 $\;\downarrow$ afferent arteriolar vasodilation $\rightarrow$
	 	 $\;\downarrow$ GFR
	- ATN: dense granular ("muddy brown") casts
- Post-renal: bladder distension, hydronephrosis on USG

### Management
- Assess **fluid status**
	- If hypovolaemic, fluid resuscitation and inotropes as needed
	- Once euvolaemic, fluid intake = urine output + 500mL (for covering
	 insensible loss)
	- If hypervolaemic, diuretics
- Manage **hyperkalaemia**
	- If K$^+$ > 6.5 mmol/L
		- **Calcium resonium** to _stabilize myocardium_
		- **Glucose + Insulin** to _reduce K_
- Manage **acidosis**
	- NaHCO$_3$ if pH < 7
- **Treat the cause**
- Discontinue nephrotoxic drugs
- Reduce doses of other drugs according to renal function
- Diet: sufficient energy and protein while avoiding high protein intake
 (as renal function is poor, metabolic wastes from protein i.e. urea
 will accumulate in blood leading to uraemia)
- **Renal replacement therapy**: if not improving with the above measures 


\pagebreak

\section [Chronic kidney disease (CKD)]
{Chronic kidney disease (CKD)\footnote{
Here's an awesome
 \href{https://www.youtube.com/watch?v=iyMw-b3Ypzw&list=TLPQMTQwNzIwMjJ11biDo7N03Q&index=15}
 {video by Ninja Nerd}
 that discusses CKD in detail with its
 pathophys, features, dx, and rx.}}

	
### Definition
- Irreversible loss of renal function developing over years (Davidson)
- Abnormalities of kidney structure or function, present for > 3 months,
 with implications for health (KDIGO)^[https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf]
- End-stage renal disease (ESRD): death likely without RRT (CKD stage 5)

### Staging
\renewcommand{\arraystretch}{1.5}
\rowcolors{2}{gray!20}{gray!40}
\begin{table}[h!]
\centering
\begin{tabular}{l m{5cm} c m{5cm}}
\cellcolor{violet!60}\color{white}Stage &
\cellcolor{violet!60}\color{white}Definition &
\cellcolor{violet!60}\color{white}Description &
\cellcolor{violet!60}\color{white}Features \\
1 & GFR $\ge$ 90 mL/min/1.73m$^2$ with evidence of kidney damage & Normal function & Asymptomatic \\
2 & GFR 60-89 & Mild CKD & Asymptomatic \\
3A & GFR 45-59 & Mild to moderate CKD & Usually asymptomatic \\
3B & GFR 30-44 & Moderate to severe CKD & Anaemia in some patients \\
4 & GFR 15-29 & Severe CKD & First symptoms often at GFR < 20. Electrolyte disorders \\
5 & GFR < 15 & Kidney failure & Significant symptoms and complications. Dialysis initiated if < 10. \\
\end{tabular}\caption{Stages of CKD}
\label{table:ckd-stage}
\end{table}


### Causes
- Diabetes mellitus
- Hypertension
- Glomerular diseases (IgA nephropathy most common)
- Tubulointerstitial diseases
- Systemic inflammatory diseases (SLE, vasculitis)
- Renal artery stenosis
- Congenital / inherited (Alport's, PKD)

### Features
- Typically detected incidentally (by raised urea & creatinine)
 during routine tests, especially in high-risk patients (e.g. DM, Htn)
- Most cases asymptomatic until GFR $\ge$ 30 mL/min
- _Nocturia_ is an early symptom, due to loss of concentrating ability.
- When GFR falls to 15-20, symptoms and signs are common.
	- Tiredness, breathlessness (due to anaemia, fluid overload)
	- Pruritus
	- Anorexia, nausea, vomiting, hiccups
	- Wt loss
	- Kussmaul breathing if profound metabolic acidosis

#### Features according to systems
- _Bone_ (**renal osteodystrophy**; mechanism Fig. \ref{fig:ckd-osteo})
	- Osteomalacia (renal rickets; due to $\downarrow$ vit-D)
	- Osteoporosis
	- Osteosclerosis ($\uparrow$ PTH $\rightarrow$ rugger jersey spine)
	- Osteitis fibrosa cystica
- _Skin_
	- Pruritus
- _Gastrointestinal_
	- Anorexia
	- Nausea
	- Vomiting
- _Metabolic_
	- **Hyponatraemia, hyperkalaemia** (due to failure of RAAS system)
	- **Hypocalcaemia, hyperphosphataemia** (mechanism
	 Fig. \ref{fig:ckd-osteo})
	- **Metabolic acidosis**
	- **Hyperuricaemia**, gout
	- **Hypercholesterolaemia**
- _Endocrine_
	- 2$^{\circ}$ hyperparathyroidism
	- Hyperprolactinaemia
- _Cardiovascular_
	- **Hypertension** ($\downarrow$GFR $\rightarrow$ $\uparrow$Renin
	 $\rightarrow\;\uparrow$Angiotensin )
	- Heart failure
	- LVH (2$^{\circ}$ to anaemia or htn)
	- Arrhythmias
	- Pericardial tamponade (uraemic pericarditis)
	 $\rightarrow\;\;\uparrow$ JVP, pulsus paradoxus 
- _Respiratory_
	- Pulmonary oedema
- _Nervous_: due to uraemic encephalopathy (azotaemia = elevated
 urea _without symptoms_ i.e. no organ damage yet, uraemia = elevated
  urea _with symptoms_)
	- Fatigue, drowsiness
	- Restless leg syndrome
	- Asterixis (flapping tremor)
	- Seizures
	- Coma
- _Muscular_

### Investigation
- Urea and creatinine: to assess stability / progression; compare to
 previous results
- CBC: to see Hb%
- RBS and HbA1c: to see DM
- Urinalysis: if haematuria / proteinuria indicate glomerular cause
- Serum electrolytes: to see Na, K, acidosis
- Ca, PO$_4^{3-}$, PTH, vit-D
- Lipid profile

### Management
#### Monitoring renal function
- GFR at least every 6 months for stage $\ge$ 3
- Plot GFR against time
	
#### Reducing rate of progression
- **Antihypertensive** therapy: Slows rate of decline irrespective
 of the medication
- **Glycaemic control:** if DM present
- **Proteinuria reduction:**
	- Protein
	- $\downarrow$ Proteinuria $\rightarrow$ risk of progression
		- As protein in the tubules trigger inflammatory damage
	- **ACEi / ARBs** can both reduce BP and reduce proteinuria
		- Reduce perfusion pressure by dilating efferent
		 arterioles $\rightarrow\;\;\downarrow$ proteinuria
		- Should be prescribed even if no htn
		- Reduce risk of cardiovascular events and all-cause
		 mortality in CKD
		- Angiotensin-II critical for GFR autoregulation in case of
		 low renal perfusion, so may exacerbate, e.g., pre-renal AKI.
		 So should be warned to stop taking the meds if fever, diarrhoea,
		 vomiting (and other potential causes of dehydration / pre-renal
		 AKI) arise, and restart after getting better.
		- Should not be commenced if baseline K$^+$ > 5.5 mmol/L, as
		 they cause hyperkalaemia
			 
#### Treatment of complications
- **Fluid & electrolyte balance**
	- **Limit protein intake**, especially in stages 4 and 5,
	 as urea will accumulate.
	- **Limit potassium intake**
	- **Limit salt intake if oedema and htn**
- **Acid-base balance**
	- $\downarrow$ excretion of acids $\rightarrow$ HAGMA (high
	 anion gap metabolic acidosis)
	- NaHCO$_3^-$ supplements
- **Renal osteodystrophy**
	- Primary factors: **$\downarrow$ PO$_4^{3-}$ excretion & vit-D
	 activation** (details: Figure \ref{fig:ckd-osteo})
	- Phosphate correction:
		- **Limit high phosphate food** e.g. milk, cheese, eggs,
		 protein-rich food
		- **Phosphate-binding drugs** e.g. CaCO$_3$, Al(OH)$_3$
	- Vit-D correction:
		- **Vit-D supplements**
- **Anaemia**
	- Causes:
		- **$\boldsymbol\downarrow$ erythropoietin**
		- Toxic effects of **uraemia** on RBCs
		- **$\boldsymbol\downarrow$ RBC survival**
		- **$\boldsymbol\uparrow$ capillary fragility** $\rightarrow$
		 blood loss
		- $\downarrow$ intake, uptake, and utilisation of dietary Fe
	- **Treatment:** recombinant human **erythropoietin**
	- Target Hb value: 10 g/dL
- **Cardiovascular risk factors**
	- Mechanism of $\uparrow$ CV disease risk in CKD
		- $\uparrow$ BP
		- Vascular tunica media calcification $\rightarrow$ stiffness
		- Inflammation, oxidative stress
		- Abnormal endothelial function
	- Treatment:
		- Regular exercise
		- Weight loss
		- Smoking cessation
		- Statins, low-dose aspirin

\pagebreak
\null
\vfill
\begin{figure}[h!]
	\centering
	\begin{subfigure}[t]{.5\textwidth}
		\includegraphics[width=\textwidth]{../assets/med/CKD-osteo.png}
		\vspace{14mm}
		\caption{Mechanism of renal osteodystrophy}
	\end{subfigure}\hfill
	\begin{subfigure}[t]{.4\textwidth}
		\includegraphics[width=\textwidth]{../assets/med/PTH-bone.png}
		\vspace{12mm}
		\caption{Mechanism of PTH-induced bone resorption}
	\end{subfigure}
	\vspace{15mm}
	\caption{PTH and renal osteodystrophy}
	\label{fig:ckd-osteo}
\end{figure}
\vfill

\pagebreak

## UTI
### Definition
- Presence of > 10$^5$ organisms/mL in a mid-stream sample of urine (if
 asymptomatic). 

### Features
- **LUTI**: cystitis/urethritis
	- Frequency
	- Urgency
	- Dysuria (burning urethral pain during micturition)
	- Haematuria
	- Strangury (intense desire to pass more urine after voiding, due to
	 spasm of inflamed bladder wall)
- **UUTI**: acute pyelonephritis
	- Fever with chills and rigor
	- Vomiting
	- Loin pain
	- Renal angle tenderness

### Commonly involved pathogens
- _E. coli_: 75%
- _Proteus_
- _Pseudomonas_
- _Streptococci_
- _Staph. epidermidis_


### Investigation
- Dipstick test for nitrites, leucocyte esterase, and glucose
	- Most urinary pathogens (e.g. _E. coli, Proteus_ etc) reduce nitrate to
	 nitrite
	- UTI $\rightarrow$ Neutrophils in urine $\rightarrow$ leucocyte esterase
- Microscopy for WBC and organisms
- Urine culture

### Treatment
#### Cystitis
- **1st choice**
	- **Trimethoprim** (200mg bds 3 days)
	- **Nitrofurantoin** (50mg qds 3 days)
- **Pregnancy**
	- Nitrofurantoin (50mg qds 7 days)
	- Cefalexin (250mg qds 7 days)
- Avoid trimethoprim during pregnancy, and nitrofurantoin at term

#### Pyelonephritis
- **1st choice**
	- **Cefalexin** (1g qds 14 days)
	- **Ciprofloxacin** (500mg bds 7 days)
- Hospitalise if no response within 24h

#### Epididymo-orchitis
- _1st choice_: Ciprofloxacin

#### Acute prostatitis
- _1st choice_: Trimethoprim

### Prophylactic measures in women with recurrent UTI
- Fluid intake $\ge$ 2L/day
- Regular complete bladder evacuation
- Emptying the bladder before and after intercourse
- Good personal hygiene
- Continuous prophylactic trimethoprim (100mg) and nitrofurantoin (50 mg) at
 night

## Renal cell cancer
### Introduction
- Peak incidence: 65-75y
- Arises from _renal tubular cells_
- Histological types:
	- **Clear cell** (most common; 85%)
	- Papillary
	- Chromophobe
	- Collecting duct

### Features
- $\approx$ 50% found incidentally (i.e. asymptomatic when diagnosed)
- $\approx$ 10% present with the **classic triad** (especially if advanced
 disease)
	- **Haematuria** ($\approx$ 60% of symptomatics)
	- **Loin pain** ($\approx$ 40% of symptomatics)
	- **Loin mass** ($\approx$ 25% of symptomatics)
- Pyrexia of unknown origin (PUO)
- Anorexia, malaise, wt loss
- **Metastasis:** ($\approx\frac{1}{4}$th have mets at presentation)
	- Lymphatic: to _para-aortic nodes_
	- Blood-borne: to _lungs, bones, brain_
	
### Investigation
- USG: to differentiate solid tumour and cyst
- CECT (contrast-enhanced CT) of abdomen and chest: for staging (
 "cannon-ball" opacities in chest)
- CBC: polycythaemia (due to $\uparrow$ erythropoietin)
- ALP: to check bony mets

### Management
- **Radical nephrectomy**
- **Partial nephrectomy**: If tumour $\le$ 4cm
- If high operative risk / patient doesn't want surgery:
	- **Cryotherapy**
	- **Radiofrequency ablation**
- If unresectable / metastatic:
	- RCC is radio-resistant and also resistant to most chemo agents
	- Current drugs of choice:
		- **Tyrosine kinase inhibitors:**
			- pazopanib, sunitinib
			- inhibit angiogenesis
		- **mTOR inhibitors** (mammalian target of rapamycin):
			- temsirolimus, everolimus
	- High-dose IL-2 
	


\pagebreak

## Stuff not large enough to devote a section to

\pagebreak

# Rheumatology
## Investigation of musculoskeletal disease
### Joint fluid aspiration
- Normal:
	- Amount small
	- Viscosity high
	- Colourless / pale yellow
- Inflammation:
	- Amount raised
	- Viscosity lowered (due to enzymatic degradation of hyaluronan & aggrecan)
	- Turbid (due to neutrophils)
- Crystal-induced arthropathies
	- Crystals seen by polarised light microscopy
	- Urate crystals $\rightarrow$ long, needle shaped, -ve birefringence
	- Ca pyrophosphate crystals $\rightarrow$ small, rhomboid, +ve
	 birefringence
	 
### Bone scintigraphy
- Dx of metastatic bone disease and Paget's
- $^{99}$Tc radiolabelled bisphosphonate used

### DEXA (Dual Emission X-ray Absorptiometry)
- Measure BMD (bone mineral density)
	- < -2.5 $\rightarrow$ osteoporosis
	- Between -2.5 and -1 $\rightarrow$ osteopoenia
	- \> 2.5 $\rightarrow$ high bone mass (most common cause osteoarthritis)

### Immunology
- **RF**
	- Antibody to Fc fragment of human Ig
	- 70% sensitive for RA (if nodules & extra-articular manifestations
	 then 100% sensitive); specificity poor
	- **RF +ve diseases**
		- Rheumatoid arthritis
		- Sjogren's syndrome
		- SLE
		- Old age (> 65)
- **ACPA**
	- Antibody to peptides in which arginine has been converted to citrulline
	 by peptidylarginine deiminase, an enzyme abundant in inflamed synovium.
	- 70% sensitive, >95% specific for RA
- **ANA** (antinuclear antibodies)
	- 100% sensitive for SLE but poor specificity
	- **ANA +ve diseases**
		- SLE
		- Sjogren's
		- Systemic sclerosis
		- Rheumatoid arthritis
- **Complement C3**
	- Active SLE $\rightarrow\;\;\downarrow$ C3  (due to consumption of C3
	 by immune complexes)

## Seropositive vs Seronegative arthritis
- Seropositive: RF+ inflammatory arthritis
	- Rheumatoid arthritis
	- SLE
- Seronegative: RF- inflammatory arthritis
	- Ankylosing spondylitis
	- Reactive arthritis
	- Psoriatic arthropathy

## Osteoarthritis
- Characterised by
	- degeneration of articular cartilage
	- subchondral osteosclerosis
	- osteophyte formation at joint margin
	- enlargement of affected joint
- Sites
	- hips
	- knees
	- PIPs
	- DIPs
	- cervical and lumbar spine
- Investigation:
	- X-ray of affected joint: findings described above in characteristics
	- MRI spine if spine OA + suspected root compression / spinal stenosis 
- Treatment
	- Conservative:
		- Wt loss
		- Exercise
		- NSAIDs
		- Intraarticular glucocorticoids
	- Surgical: if refractory
		- Total joint replacement
		- Osteotomy

## Spondyloarthropathies
- Asymmetrical oligoarthrites associated with HLA-B27 and typically involving
 the spine
	- Ankylosing spondylitis
	- Reactive arthritis
	- Psoriatic arthropathy
	- Axial spondyloarthritis
	- Entropathic spondyloarthritis (arthritis associated with IBD)
- Common features:
	- Asymmetric oligoarthritis
	- Sacroilitis
	- Enthesitis (inflammation where tendon attaches to bone)

### Reactive arthritis
- "Reactive" to certain infections e.g. _Chlamydia, Campylobacter
 Salmonella, Shigella_.
- **Reiter's syndrome**:
	- Triad of _can't see, can't pee, can't bend the knee_
		- **Conjunctivitis**
		- **Urethritis**
		- **Reactive arthritis**
	- Due to _Chlamydia_

\pagebreak

# Neurology
## Raised ICP
- Normal ICP = **5-15 mmHg**

### Causes
- **ICSOL**
	- Intracranial haemorrhage
	- Tumours e.g. glioma
	- Brain abscess
- **Hydrocephalus**: blockade of CSF circulation
	- Obstructive / non-communicating
	- Communicating
- **Cerebral oedema** e.g. meningoencephilitis
- **Venous sinus obstruction** e.g. cerebral venous thrombosis

### Features
- **Headache**
- **Vomiting**
- **Diplopia / blurred vision**: Due to _6th nerve palsy_
	- 6th nerve palsy due to
		- stretching of the long, slender nerve
		- compression against petrous temporal bone
	- This palsy of the 6th nerve secondary to raised ICP is known as a
	 _false localisation sign_. If the patient presented only with visible
	 features of 6th nerve palsy, (e.g. diplopia, medial squint) we would
	 falsely localise the primary defect to the 6th nerve. So in
	 6th nerve palsy always exclude RICP by looking for papilloedema. 
- **Depressed consciousness**
- **Papilloedema**
- **Bradycardia**
- **Hypertension**

### Management
- According to cause:
	- Mass lesion $\rightarrow$ surgical decompression
	- Hydrocephalus $\rightarrow$ _ventriculoperitoneal shunt_ operation
	- Oedema $\rightarrow$ glucocorticoids
- Supportive:
	- Head elevation
	- Fluid balance
	- BP control
	- Diuretics: mannitol

## Neurological emergencies
- **Status epilepticus**
- **Stroke** (if thrombo)
- **Subarachnoid haemorrhage**
- **Cord compression**
- **GBS**
- **Myasthenia gravis** (if bulbar and/or respiratory)

\pagebreak

## Status epilepticus
### Definition
- Continuous or recurrent **seizures** for **$\ge$ 30 mins without gain of
 consciousness** in between.
- Clinically we assume SE after 5mins of seizure activity.

### Management
\begin{figure}
	\centering
	\includegraphics[width=.7\textwidth]{../assets/med/stat-epi.png}
	\vspace{7mm}
	\caption{Management algorithm for status epilepticus}
\end{figure}

## All jerks root values
- Biceps: C5
- Supinator: C6
- Triceps: C7
- Finger (aka Hoffmann test): C8
- Knee: L3, L4
- Ankle: S1, S2
- Plantar: S1 (technically not a jerk since it's a superficial reflex)

\pagebreak

## Subarachnoid haemorrhage
### Causes
- Ruptured berry aneurysm (85%)
- Arterio-venous malformations

### Features
- Sudden severe "thunderclap" headache (often occipital)
- Vomiting
- High BP
- Neck stiffness
- May be loss of consciousness
- Photophobia

### Investigation
- CT scan: hyperdense material in the subarachnoid space
- Lumbar puncture: blood, xanthochromia

### Management
- **Nimodipine** 30-60mg IV for 5-14d, followed by 360mg oral for 7d
	- _prevents delayed ischaemia_
- Insertion of **Pt coils** into aneurysm
- **Surgical clipping** of the neck of the aneurysm
- Surgical removal if AVM

## Subacute combined degeneration
### Features
- **Peripheral neuropathy**: due to **demyelination**
- Signs of **dorsal column lesion**: **position and vibration sense lost**
- Signs of **pyramidal lesion**:
	- **plantar extensor**
	- **knee jerk brisk**
	- **ankle jerk absent**: as peripheral neuropathy affects longer nerves
	 first, the afferent pathway for ankle jerk is damaged by the PN while
	 the same for knee jerk is not. Combined with the corticospinal tract
	 lesion, this makes knee jerks brisk and ankle jerks absent.
- **Optic atrophy**:  death of retinal ganglion cell axons

\pagebreak

## Cauda equina and Conus medullaris lesions
### Anatomy
\begin{figure}[h!]
	\begin{subfigure}[b]{.4\textwidth}
		\includegraphics[width=\textwidth]{../assets/med/cauda.jpg}
		\vspace*{10mm}
		\caption{The Conus and the Cauda}
	\end{subfigure}\hfill
	\begin{subfigure}[b]{.4\textwidth}
		\includegraphics[width=\textwidth]{../assets/med/cauda-2.jpg}
		\caption{Vertebrae with corresponding spinal cord segments}
	\end{subfigure}
\end{figure}

- During development, the spine grows faster than the spinal cord, which
 is why the spinal nerves exit the spinal column at increasingly oblique
 angles.
- The spinal cord ends as the tapered conus medullaris at around L1.

\pagebreak

### Relevant physiology
- S2-4:
	- Parasympathetic fibres for bladder sphincter (activation causes
	 emptying)
	- Somatic fibres for pudendal nerves (activation causes relaxation of
	 urethral and anal sphincters $\rightarrow$ emptying).
- Conus is surrounded by spinal nerve roots bundled up together around it,
 so injury / compression in this region leads to a combination of UMN
 and LMN lesion features.
- Lesion in the cauda region leads only to LMN lesion features as there's
 no cord there.

### Features of Cauda Equina syndrome vs Conus Medullaris syndrome
\begin{figure}
\centering
\includegraphics[width=.7\textwidth]{../assets/med/cauda-vs-conus-1.png}
\end{figure}
\begin{figure}
\centering
\includegraphics[width=.75\textwidth]{../assets/med/cauda-vs-conus-2.png}
\vspace{10mm}
\end{figure}


## Neurogenic Bladder
### Physiological control of micturition: the Micturition Reflex
#### "Components"
- **Detrusor muscle**
	- Muscles of the bladder wall
	- Innervated by
		- **Parasympathetic:** 
			- cholinergic M$_3$ receptors
			- pelvic nerve from **S2-4**
			- causes **contraction** $\rightarrow$ **urination**
		- **Sympathetic:** 
			- $\beta_3$ receptors
			- hypogastric nerve from **T10-L2**
			- causes **relaxation** $\rightarrow$ **storage** / retention
- **Internal urethral sphincter**
	- Innervated by **only sympathetic**
		- hypogastric nerve from **T10-L2**
		- causes storage / retention
- **External urethral sphincter**
	- **Voluntary control** 
		- UMN from pontine micturition centre
		- LMN from S2-4 (pudendal nerve)
		- causes retention

#### The big picture (highest yield for clinical interpretation)
\begin{figure}
\centering
\includegraphics[width=.6\textwidth]{../assets/med/micturition-reflex.png}
\end{figure}


\begin{center}
$\fbox{Lesion in S}$ $\rightarrow$ $\fbox{Stores (retention)}$\\
$\fbox{Lesion in L and above}$ $\rightarrow$ $\fbox{Leaks (incontinence)}$\\

\end{center}

- The reflex spontaneously tries to void the bladder upon being filled
 even by small amounts. The only thing holding it back is the pontine
 micturition centre which always inhibits the circuit, unless we voluntarily
 signal it not to. We can't signal the bladder to empty itself. We can only
 signal the micturition reflex to not hold back.
- The reflex circuit is composed of afferents and efferents from S2-4.
 So any **lesion above S2-4** will leave the circuit intact, while damaging
 the telephone lines from the pontine centre. The end result is that we lose
 the inhibition of the reflex (which fires every few mins after storing
 some tens of millilitres of urine), and without anything holding it back,
 there's urinary **incontinence**.
- On the other hand, any **lesion at S2-4** will damage the circuit
 elements themselves. That means that the reflex will be lost. This means
 we no longer have access to the bladder emptying circuit. So
 there will be urinary **retention**.

\pagebreak
#### The details
\begin{figure}
	\centering
	\begin{subfigure}{.4\textwidth}
		\includegraphics[width=\textwidth]{../assets/med/mic-part.png}
		\vspace{6mm}
		\caption{Partly filled bladder}
	\end{subfigure}\hfill
	\begin{subfigure}{.55\textwidth}
		\includegraphics[width=\textwidth]{../assets/med/mic-filled.png}
		\vspace{6mm}
		\caption{Fully filled bladder}
	\end{subfigure}
	\vspace{10mm}
	\caption{Neural control of micturition}

\end{figure}

\pagebreak
## Parkinson's disease
### Parkinsonism
- Triad of **TRH**: tremor, rigidity, hypokinesia (bradykinesia)
- **Causes**
	- Idiopathic $\rightarrow$ Parkinson's disease
	- Cerebrovascular disease
	- Drugs:
		- Antipsychotics (older)
		- Metoclopramide (D$_2$ blocker $\rightarrow$ undo D$_2$
		 mediated inhibition of cholinergic stimulation in GIT $\rightarrow$
		 $\uparrow$GI motility $\rightarrow$ antiemesis)
		 	- Domperidone, which is also a D$_2$ blocker, selectively acts
		 	 on D$_2$s in the GIT, so no parkinsonism 
		 	- Metoclopramide is nonselective
		- Na-valproate, Lithium
	- Other neurodegenerative diseases
		- Lewy body dementia
		- Multiple system atrophy
		- Alzheimer's
	- Genetic
		- Huntington's
		- Wilson's

### Pathophysiology
- Loss of pigmented dopaminergic neurons in substantia nigra
- **Lewy bodies in nigral cells**: pathological hallmark
	- Eosinophilic cytoplasmic inclusions
	- Lewy body = aggregation of $\alpha$-synuclein (hence the
	 alternative name $\alpha$-synucleinopathy)
	- Other $\alpha$-synucleinopathies (diseases associated with Lewy body
	 deposition (differ in the initial site of deposition and hence
	 initial features)):
		- Lewy body dementia
		- Multiple system atrophy


### Features
- Average age of onset: 60y
- First degreee relative with PD $\rightarrow$ 2-3x risk
- Progressive, incurable
- Initially motor symptoms dominate, but eventually nonmotor symptoms
 (e.g. depression, anxiety, cognitive impairment) become increasingly
 prominent
- Motor symptoms **initially asymmetrical**
- The hallmark is **bradykinesia**, which leads to
	- Micrographia (small handwriting)
	- Difficulty tying shoelaces / buttoning clothes
	- Difficulty rolling over in bed
- **Resting tremor** affecting limbs, chin and jaw but not the head
- **Rigidity**
- Soft, indistinct speech

#### Signs
- General:
	- Hypomimia (expressionless / mask-like face)
	- Dysphonia (soft, indistinct speech)
	- Flexed (stooped) posture with impaired postural reflexes
	- Bradykinesia
	- **Glabellar tap:**
		- tapping on glabella (above bridge of nose) $\rightarrow$ blink
		- normal $\rightarrow$ blinking stops after 3-5 times
		- Parkinson's $\rightarrow$ sustained blinking
- Gait: **Festinating gait**
	- Slow to start
	- Short, shuffling steps (festination)
	- Reduced arm swing
	- Impaired balance on turning (fractionated turn)
- Tremor:
	- First in arm/hand (**pill-rolling** tremor)
- Rigidity:
	- **Leadpipe rigidity**: 
		- better seen in elbow / knee
		- uniform throughout movement
	- **Cogwheel rigidity** (= tremor superimposed on rigidity) better
	 seen in wrist
	- Rigidity vs Spasticity:
		- Rigidity:
			- uniform resistance throughout range of motion
			- due to _extrapyramidal_ lesion
		- Spasticity:
			- initially increased resistance, followed by lessening
			- due to _pyramidal_ lesion
- The following will be normal (if abnormal, consider other causes)
	- Power, jerks, plantar
	- Eye movements
	- Sensory exam
	- Cerebellar exam

### Investigation
- Dx is clinical
- CT / MRI normal
- Functional dopaminergic imaging (SPECT / PET) abnormal even early
- In younger, exclude Huntington's and Wilson's

### Treatment
- **Only symptomatic, no cure**
- **Physiotherapy $\pm$ drugs** (drugs not given if mild)
- **Surgical:** on failure of medical therapy

#### Drugs
- **Levodopa + carbidopa**
	- Most effective in reducing **rigidity and bradykinesia**
	- **Role of dietary protein**: amino acids in dietary protein compete
	 with levodopa for intestinal absorption and transport across BBB
	 $\rightarrow\;\;\downarrow$ efficacy of levodopa
	- Side effects:
		- Postural hypotension
		- Nausea, vomiting
		- Hallucinations
	- Fluctuating response after 3-5y of use
		- _End of dose dyskinesia_: due to progressive loss of dopamine,
		 duration of action of levodopa becomes shorter. Freezing and
		 rigidity before next dose of levodopa.
		 	- Management: smaller, frequent dosage
		- _On-off phenomenon_: periods of severe parkinsonism (freezing
		 and immobility - _off period_) alternating with periods of
		 dopamine-induced dyskinesia / chorea (_on period_).
		 	- Management: lower levodopa dose, add selegiline with levodopa
	- Contraindications:
		- Psychosis
		- Narrow angle glaucoma
		- Malignant melanoma
		- PUD
- **Anticholinergics**
	- Benzhexol, benztropine, trihexyphenidyl
	- Reduce **tremor and rigidity**, not bradykinesia
	- Side effects:
		- Urinary retention, constipation, dry mouth
		- Worsening of glaucoma
	- Contraindications:
		- BEP
		- Narrow angle glaucoma
- **Dopamine receptor agonists**
	- Ergot-derived (e.g. bromocriptine) or non-ergot-derived (e.g.
	 ropinirole)
	- Compared to levodopa, less therapeutic effect, more side effects
	- Side effects:
		- Postural hypotension
		- Nausea, vomiting
		- Hallucination
		- Confusion
- **MAO-B inhibitors**
	- Selegiline, rasagiline
	- MAO-B facilitates dopamine breakdown $\rightarrow$ MAO-Bi potentiates
	 the action of levodopa by inhibiting breakdown
- **COMT inhibitors**
	- Tolcapone, entacapone
	- COMT $\rightarrow$ peripheral breakdown of levodopa
- **Amantadine**:
	- Rarely used unless patient unable to tolerate other drugs.
 	- Mild, short-lived effect.

#### Surgery
- **Deep brain stimulation**
	- Replaced destructive surgery
	- Targets: thalamus, globus pallidus, subthalamic nuclei
	- Thalamic stimulation $\rightarrow$ reduce tremor

\pagebreak
# Diabetes Mellitus
## Mechanism of insulin secretion
\begin{figure}
\centering
\includegraphics[width=.7\textwidth]{../assets/med/insulin-secr.jpg}
\caption{Mechanism of insulin secretion}
\end{figure}

## Incretin effect
For the same glucose load applied orally and IV, the **oral load stimulates
 more insulin secretion** (because oral load $\rightarrow$ release of gut
 peptides GLP-1 and GIP $\rightarrow\;\;\uparrow$ insulin secretion).

\vfill

\begin{figure}[h!]
\centering
\includegraphics[width=.4\textwidth]{../assets/med/incretin.png}
\vspace{10mm}
\caption{The incretin effect}
\end{figure}

## Diagnostic criteria
- If _symptomatic_, any one of the following
	- FBS $\ge$ 7.0 mmol/L
	- RBS / 2h after OGTT $\ge$ 11.1 mmol/L
	- HbA1c > 6.5%
- If _asymptomatic_, two positives needed for dx.
- IFG: 
	- FBS between 6.1-6.9 mmol/L, 2h after OGTT < 7.8 mmol/L (WHO)
	- FBS between 5.6-6.9 mmol/L (American diabetes association (ADA))
- IGT:
	- FBS < 7.0 mmol/L, 2h after 7.8-11 mmol/L

\pagebreak

## Diabetic ketoacidosis (DKA)
- **Medical emergency**
- Cause of death
	- Children: cerebral oedema
	- Adults:
		- **Hypokalaemia**
		- ARDS
		- Comorbidities: acute MI, sepsis, pneumonia
- **Cardinal biochemical features**
	- Hyperglycaemia $\rightarrow$ osmotic diuresis $\rightarrow$ dehydration,
	 dyselectrolytaemia
	- Hyperketonaemia:
		- Insulin deficiency + elevated catecholamines $\rightarrow$
		 unrestrained lipolysis to make FFA $\rightarrow$ hepatic
		 ketogenesis
	- Metabolic acidosis

### Clinical features
- **Symptoms**
	- Polyuria, thirst
	- Weakness
	- Nausea, vomiting
	- Abdominal pain
	- Blurred vision
- **Signs**
	- Dehydration
	- Hypotension
	- Tachycardia
	- Air hunger / Kussmaul breathing (deep and sighing breathing)
	- Acetone breath
	- Delirium, drowsiness, coma

### Management
- **Establish IV access**
- **Volume replacement: 0.9% NaCl **
	- If systolic BP $\ge$ 90mmHg: 1L over 1h
	- Else: $\frac{1}{2}$L over 15mins $\rightarrow$ reassess.
	 If BP still < 90mmHg, repeat.
- **Insulin therapy**: **IV** 0.1 U/kg/h
	- Corrects hyperglycaemia & acidosis
- **Monitor**
	- Every 1h: 
		- capillary blood glucose and ketone
		- vitals: pulse, BP, resp rate, O$_2$ sat, urine output
	- Every 2h: Venous HCO$_3^{-}$ and K$^+$
	- Every 4h: Serum electrolytes
- If K$^+$ is low, 40mmol/L KCl with normal saline

## Hypoglycaemia
### Features
- **Autonomic**
	- Sweating
	- Trembling
	- Palpitations
- **Neuroglycopoenic**
	- Delirium
	- Drowsiness
	- Speech difficulty
	- Incoordination

### Management
\begin{figure}
\centering
\includegraphics[width=.7\textwidth]{../assets/med/hypogly.png}
\vspace{5mm}
\caption{Managing hypoglycaemia}
\end{figure}

- Oral fast-acting carbohydrate (10-15g) e.g. glucose drink / confectionery
 / honey to buccal mucosa
- Repeat capillary glucose measurement 10-15mins later
	- If still hypo, repeat upto 3 cycles
	- Still hypo after 3 cycles $\rightarrow$ glucagon 1mg IM

\pagebreak

## Insulin therapy
### Indications
- Type I DM
- Type II DM not controlled by OHA
- DIP / GDM
- DKA
- Hyperkalaemia

### Preparations
- **Rapid-acting** (rapid=LAG-less)
	- Lispro
	- Aspart
	- Glulisine
- **Short-acting:** soluble/regular insulin
- **Intermediate-acting:** Isophane (I for I)
- **Long-acting**
	- Glargine (gLARGE-in)
	- Detemir
Route of administration: **subcutaneous**

## Oral Hypoglycaemic Agents
- **Biguanides**: Metformin
	- Insulin _sensitiser_
	- **Mechanism of action**
		- $\downarrow$ hepatic glucose production (gluconeogenesis and
		 glycogenolysis)
		- $\uparrow$ gut glucose uptake & utilisation
		- weak inhibitor of mitochondrial respiration $\rightarrow\;$
		 $\uparrow$ AMP, $\downarrow$ ATP $\rightarrow\;\;\uparrow$
		  glucose uptake utilisation etc.
	- **Side effects profile**
		- Weight neutral
		- Non-hypoglycaemic
		- _Lactic acidosis_
- **Sulphonylureas**: Glibenclamide, Gliclazide, Glimepiride
	- Insulin _secretagogue_
	- **Mechanism of action:** Block K$^+$ channel in $\beta$-cells
	 $\rightarrow\;\;\uparrow$ insulin secretion 
	- **Side effects profile**
		- Wt gain
		- Hypoglycaemia
- **$\alpha$-glucosidase inhibitors:** Acarbose
	- **Mechanism of action**: delay absorption of carbs
	- **Side effects profile**
		- Non-hypoglycaemic
		- Flatulence
		- Bloating
		- Diarrhoea
- **Incretin-based therapies:**
	- **DPP-4 inhibitors:** Gliptins
		- **MoA**
			- DPP-4: breaks down GLP-1 & GIP $\rightarrow$ inhibit incretin
			 effect
	- **GLP-1 receptor agonists:** Exenatide, liraglutide 
- **Thiazolidinediones:** Pioglitazone
	- **Mechanism of action**
		- PPAR-$\gamma$ agonist $\rightarrow$ enhance action of insulin
	- **Side effects profile**
		- Non-hypoglycaemic
		- Wt gain (increase fat cells)
- **SGLT-2 inhibitors:** empagliflozin, dapagliflozin
	- **MoA:** inhibit reabsorption of glucose in renal tubules $\rightarrow$
	 25% of filtered glucose excreted
	- Resulting glycosuria can lead to genital fungal infections
	- Empagliflozin $\rightarrow$ 35% reduced mortality in heart failure


## Complications of DM
### Acute complications
- Hypoglycaemia
- Diabetic ketoacidosis
- Hyperglycaemic hyperosmolar state (HHS)
- Lactic acidosis

### Long-term complications
#### Microvascular
- Diabetic **neuropathy**: peripheral neuropathy (sensory, motor or mixed),
 mononeuritis multiplex, autonomic neuropathy
- Diabetic **nephropathy**
- Ocular complications:
	- Diabetic **retinopathy**
	- **Cataract**
- Foot complications: ulcer, gangrene
	- Causes of diabetic ulcer:
		- ischaemia
		- neuropathy
		- combined ischaemia and neuropathy
		- trauma
		- infection


#### Macrovascular
- **Coronary**: myocardial ischaemia, infarction
- **Cerebral**: Cerebrovascular disease
- **Peripheral**: ischaemia, claudication

\pagebreak

## Pathogenesis of chronic complications
- **\fbox{Thickened basement membrane}** and
 **\fbox{$\boldsymbol\uparrow$ vascular permeability}** are the
 pathophysiological hallmarks
 
### Mechanisms
- Formation of **advanced glycation end-products (AGEs)**
	- Nonenzymatic addition of glucose to proteins
	- Exert effects by both binding to receptors (RAGE) on endothelial,
	 inflammatory and smooth muscle cells, and by direct (non-receptor)
	 cross-linking of collagen in the basement membrane,
	 mediated chiefly by **VEGF** and **TGF-$\boldsymbol\beta$**
	 (details: fig. \ref{fig:dm-age})
- Excess activation of **protein kinase C (PKC)**
	- Mechanism: $\uparrow$intracellular glucose $\rightarrow$ $\uparrow$DAG synthesis
	 (diacyl glycerol) $\rightarrow$ $\uparrow\bigoplus$PKC $\rightarrow$
	 $\uparrow$VEGF, TGF-$\beta$, PAI-1 (plasminogen activator inhibitor-1)
	 production by the vascular endothelium
- **Oxidative stress** and **sorbitol accumulation**
	- Mechanism: $\uparrow$intracellular glucose $\rightarrow$
	 $\uparrow$metabolism to sorbitol (by aldose reductase)
	 $\rightarrow$ fructose using _NADPH_ $\rightarrow$ NADPH used up
	 $\rightarrow$ $\downarrow$availability for use in antioxidant
	 pathway $\rightarrow$ $\uparrow$ROS-mediated damage
	- Accumulation of sorbitol in the lens $\rightarrow$ cataract
	  


\pagebreak

\null
\vfill
\begin{figure}[h!]
	\centering
	\includegraphics[width=1\textwidth]{../assets/med/DM-AGE.png}
	\vspace{12mm}
	\caption{Mechanisms of AGE-induced microvascular pathology}
	\label{fig:dm-age}
\end{figure}
\vfill

\pagebreak

## Stuff not large enough to devote a section to
### Metabolic syndrome
- AKA **insulin resistance syndrome** or **syndrome X**
- Type 2 DM associated with central obesity + htn + dyslipidaemia (high
 TGs/LDLs and/or low HDL)
- Often associated with
	- Nonalcoholic fatty liver disease (NAFLD)
	- PCOS
- $\uparrow$risk of stroke, CAD


\pagebreak

# Gastrointestinal diseases
## Weight loss
### Causes
- **Endocrine**
	- DM (more in type I)
	- Thyrotoxicosis
	- Addison's
- **GI**
	- Any cause of dysphagia e.g.
		- Stroke
		- MS
		- Ca oesophagus
		- Achalasia cardia
		- Plummer-Vinson syndrome (oesophageal webs+IDA)
	- Malabsorption syndrome
		- IBD
		- Chronic pancreatitis (due to enzyme insufficiency)
		- Coeliac disease
- **Malignancies**
- **Chronic infection**
	- TB
	- AIDS
- **Psychological**
	- Depression
	- Anorexia nervosa
	- Bulimia nervosa
	- Alcoholism


# Haematology
## Chronic myeloid leukaemia (CML)
Defining characteristic: **Philadelphia chromosome**

- Shortened **chr22** by _reciprocal translocation_ with **chr9**
- Results in **BCR-ABL fusion gene**
- BCR-ABL codes for a **tyrosine kinase** which influences cell
 proliferation and survival

### Features
- Wt loss
- Lethargy
- Abdominal discomfort
- Splenomegaly
- Hepatomegaly

### Phases
- Chronic
- Accelerated
- Blastic crisis

### Investigation
- **CBC:** anaemia, leucocytosis
- **PBF:**
	- Full range of granulocytic precursors, from _myeloblasts_ to _mature
 neutrophils_. 
 	- Predominant: neutrophils and myelocytes.
 	- Myeloblasts < 10%.
- **Bone marrow examination: **
	- Hypercellular marrow
	- $\uparrow$ M/E ratio
	- $\downarrow$ erythrpoiesis
	- $\uparrow$ leucopoiesis
- **Chromosome analysis** to detect Ph chromosome

### Management
#### Chronic phase
- **1st line: Tyrosine kinase inhibitors (TKIs):**
	- **Imatinib**
	- **Dasatinib**
	- **Nilotinib**
	- normalise blood count within a month, complete cytogenetic response
	  (disappearance of Ph chr) within 6 months in 90% patients. Resample
	  bone marrow at 6mo to confirm. Thereafter monitor 3-monthly by RT-PCR
	  for BCR-ABL mRNA transcripts.
- **Allogeneic HSC transplant:** if TKI fails
- **Hydroxycarbamide**
- **Interferon:** in pregnancy

\pagebreak

# Nutritional diseases
## Vitamins
### B$_1$ (thiamin) deficiency
#### Functions of thiamin
- Cofactor in different pathways of aerobic metabolism of glucose
	- decarboxylation of pyruvate to acetyl-coA (so bridge between glycolysis
	 and Krebs)
	- decarboxylation of $\alpha$-ketoglutarate to succinate in Krebs

#### Features
- For its pivotal role in aerobic glucose meta, the largest blow is dealt
 to the tissues most dependent on glucose - the **brain** and the **heart**.
- **Beri-beri**
	- **Dry:** Neurological beri-beri
		- Peripheral neuropathy
		- Wrist/foot drop
		- **Korsakoff's psychosis**
		- **Wernicke's encephalopathy**
	- **Wet:** Cardiac beri-beri (wet as it causes generalised oedema)
		- Biventricular failure
		- Generalised oedema
		- Pulmonary oedema

#### Treatment
- Wet and Wernicke's should be treated by IV vit-B and C mixture
- Korsakoff's: irreversible, nonresponsive to thiamin
	

### B$_{12}$ deficiency
#### Functions of B$_{12}$
- Recycles folate $\rightarrow$ essential for **cell division**
 (especially in RBC)
- **Myelination**

#### Features
- **Megaloblastic anaemia**
- **Glossitis**
- **Neurologic features**
	- Peripheral neuropathy
	- Autonomic neuropathy
	- Optic atropy
	- Subacute combined degeneration of spinal cord

#### Treatment
- Vit-B$_{12}$ IM
- If combined folate and B$_{12}$ deficiency, only folate should not be
 given without B$_{12}$, as B$_{12}$ gets used up in folate recycling,
 deteriorating the B$_{12}$ deficiency symptoms. Always give both together.
